Publikasjoner

• Leiknes JB, Hiorth A, Havnen J, Greve OJ, Kurz KD, Larsen AI. Estimating cardiac output from coronary CT angiography: an individualized compartment model in comparison to the Stewart-Hamilton method. Front Cardiovasc Med. 2023 Nov 20;10:1156332. doi: 10.3389/fcvm.2023.1156332. PMID: 38054087; PMCID: PMC10694230.

 

• Instenes I, Breivik K, Borregaard B, Larsen AI, Allore H, Bendz B, Deaton C, Rotevatn S, Norekvål TM; CONCARD(PCI) investigators. Phenotyping Self-Reported Health Profiles in Octogenarians and Nonagenarians After Percutaneous Coronary Intervention: A Latent Profile Analysis. Heart Lung Circ. 2023 Nov;32(11):1321-1333. doi: 10.1016/j.hlc.2023.09.004. Epub 2023 Nov 3. PMID: 37925313.

 

 

• Sourour N, Riveland E, Omland T, Kjekshus H, Larsen AI, Røsjø H, Myhre PL. Re: Detailed association between B-type natriuretic peptide levels and ventricular tachyarrhythmia. Clin Cardiol. 2023 Dec;46(12):1604-1605. doi: 10.1002/clc.24145. Epub 2023 Oct 23. PMID: 37872822; PMCID: PMC10716318.

 

• Larsen AI. Tools for Timing in Heart Failure; what - when - how? Eur J Prev Cardiol. 2023 Aug 31:zwad281. doi: 10.1093/eurjpc/zwad281. Epub ahead of print. PMID: 37652028.

 

 

• Johansson U, Isaksen K, Dalen I, Larsen AI. Radial Artery Occlusion after Coronary Angiography with Trans Radial Access A nurse led study employing duplex ultrasonography and the reverse Barbeau test. Eur J Cardiovasc Nurs. 2023 Aug 31:zvad090. doi: 10.1093/eurjcn/zvad090. Epub ahead of print. PMID: 37648677.

 

• Sourour N, Riveland E, Naesgaard P, Kjekshus H, Larsen AI, Omland T, Røsjø H, Myhre PL. N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study. Clin Cardiol. 2023 Aug;46(8):989-996. doi: 10.1002/clc.24074. Epub 2023 Jul 3. PMID: 37400982; PMCID: PMC10436794.

 

 

• Larsen AI, Sæland C, Vegsundvåg J, Skadberg MS, Nilsen J, Butt N, Ushakova A, Valborgland T, Munk PS, Isaksen K. Aerobic high-intensity interval exercise training in patients with angina and no obstructive coronary artery disease: feasibility and physiological effects. Eur Heart J Open. 2023 Mar 22;3(2):oead030. doi: 10.1093/ehjopen/oead030. PMID: 37113515; PMCID: PMC10127938.

 

• Røysland IØ, Ueland VI, Larsen AI. Reassured on a background of vulnerability - people with microvascular angina 12 months after high-intensity physical exercise program. Int J Qual Stud Health Well-being. 2023 Dec;18(1):2162452. doi: 10.1080/17482631.2022.2162452. PMID: 36578152; PMCID: PMC9809340.

 

 

• Gyldenkerne C, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Erik Bøtker H, Engstrøm T, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Rosen HC, Stone GW, Erlinge D. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II. Circulation. 2023 Feb 7;147(6):469-481. doi: 10.1161/CIRCULATIONAHA.122.061983. Epub 2022 Dec 16. PMID: 36524476.

 

• Svane J, Wiktorski T, Ørn S, Eftestøl TC. Optimizing support vector machines and autoregressive integrated moving average methods for heart rate variability data correction. MethodsX. 2023 Sep 16;11:102381. doi: 10.1016/j.mex.2023.102381. PMID: 37753351; PMCID: PMC10518477.

 

 

• Erevik CB, Kleiven Ø, Frøysa V, Bjørkavoll-Bergseth M, Chivulescu M, Klæboe LG, Dejgaard L, Auestad B, Skadberg Ø, Melberg T, Urheim S, Haugaa K, Edvardsen T, Ørn S. Myocardial inefficiency is an early indicator of exercise-induced myocardial fatigue. Front Cardiovasc Med. 2023 Jan 11;9:1081664. doi: 10.3389/fcvm.2022.1081664. PMID: 36712275; PMCID: PMC9874326.

 

• Andersen T, Ueland T, Aukrust P, Nilsen DWT, Grundt H, Staines H, Pönitz V, Kontny F. Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin. Front Cardiovasc Med. 2023 Sep 4;10:1191055. doi: 10.3389/fcvm.2023.1191055. PMID: 37731526; PMCID: PMC10507464.

 

 

• Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I. Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly. Antioxidants (Basel). 2023 May 26;12(6):1157. doi: 10.3390/antiox12061157. PMID: 37371887; PMCID: PMC10295173.

 

• Nilsen DWT. Prognostic Potential of Total Bilirubin in Secondary CVD Prevention. JACC Asia. 2023 Feb 7;3(2):252-254. doi: 10.1016/j.jacasi.2022.12.001. PMID: 37181384; PMCID: PMC10167513.

 

 

• Nilsen DWT, Røysland M, Ueland T, Aukrust P, Michelsen AE, Staines H, Barvik S, Kontny F, Nordrehaug JE, Bonarjee VVS. The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thromb Haemost. 2023 May;123(5):510-521. doi: 10.1055/s-0042-1760256. Epub 2022 Dec 31. PMID: 36588289; PMCID: PMC10113036.

 

• Myrmel GMS, Steiro OT, Tjora HL, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Pedersen ER, Vikenes K, Omland T, Aakre KM. Prognostic value of growth differentiation factor-15 3 months after an acute chest pain admission. Heart. 2023 Nov 24:heartjnl-2023-323260. doi: 10.1136/heartjnl-2023-323260. Epub ahead of print. PMID: 38000899.

 

 

• Steiro OT, Langørgen J, Tjora HL, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Steinsvik T, Lindahl B, Omland T, Aakre KM, Vikenes K. Prognostic significance of chronic myocardial injury diagnosed by three different cardiac troponin assays in patients admitted with suspected acute coronary syndrome. Clin Chem Lab Med. 2023 Nov 9. doi: 10.1515/cclm-2023-0336. Epub ahead of print. PMID: 37937808.

 

• Myrmel GMS, Steiro OT, Tjora HL, Langørgen J, Bjørneklett R, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Pedersen EKR, Vikenes K, Omland T, Aakre KM. Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction. Clin Chem. 2023 Jun 1;69(6):649-660. doi: 10.1093/clinchem/hvad015. PMID: 36994764.

 

 

• Nilsen DWT, Røysland M, Ueland T, Aukrust P, Michelsen AE, Staines H, Barvik S, Kontny F, Nordrehaug JE, Bonarjee VVS. The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thromb Haemost. 2023 May;123(5):510-521. doi: 10.1055/s-0042-1760256. Epub 2022 Dec 31. PMID: 36588289; PMCID: PMC10113036.
• Nilsen DWT, Røysland M, Ueland T, Aukrust P, Michelsen AE, Staines H, Barvik S, Kontny F, Nordrehaug JE, Bonarjee VVS. The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thromb Haemost. 2023 May;123(5):510-521. doi: 10.1055/s-0042-1760256. Epub 2022 Dec 31. PMID: 36588289; PMCID: PMC10113036.

 

• Gerhardt T, Gerhardt LMS, Ouwerkerk W, Roth GA, Dickstein K, Collins SP, Cleland JGF, Dahlstrom U, Tay WT, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Lam CSP, Tromp J, Angermann CE. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. Lancet Glob Health. 2023 Dec;11(12):e1874-e1884. doi: 10.1016/S2214-109X(23)00408-4. PMID: 37973338.
• Ouwerkerk W, Belo Pereira JP, Maasland T, Emmens JE, Figarska SM, Tromp J, Koekemoer AL, Nelson CP, Nath M, Romaine SPR, Cleland JGF, Zannad F, van Veldhuisen DJ, Lang CC, Ponikowski P, Filippatos G, Anker S, Metra M, Dickstein K, Ng LL, de Boer RA, van Riel N, Nieuwdorp M, Groen AK, Stroes E, Zwinderman AH, Samani NJ, Lam CSP, Levin E, Voors AA. Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. J Am Coll Cardiol. 2023 Nov 14;82(20):1921-1931. doi: 10.1016/j.jacc.2023.08.053. PMID: 37940229.
• Baumhove L, Bomer N, Tromp J, van Essen BJ, Dickstein K, Cleland JG, Lang CC, Ng LL, Samani NJ, Anker SD, Metra M, van Veldhuisen DJ, van der Meer P, Voors AA. Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D. Int J Cardiol. 2024 Feb 1;396:131384. doi: 10.1016/j.ijcard.2023.131384. Epub 2023 Sep 21. PMID: 37739044.
• Tromp J, Ezekowitz JA, Ouwerkerk W, Chandramouli C, Yiu KH, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Collins SP, Filippatos G, Cleland JGF, Lam CSP. Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. JACC Heart Fail. 2023 Sep;11(9):1262-1271. doi: 10.1016/j.jchf.2023.06.028. PMID: 37678961.
• Katsanos S, Ouwerkerk W, Farmakis D, Collins SP, Angermann CE, Dickstein K, Tomp J, Ertl G, Cleland J, Dahlström U, Obergfell A, Ghadanfar M, Perrone SV, Hassanein M, Stamoulis K, Parissis J, Lam C, Filippatos G. Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. ESC Heart Fail. 2023 Oct;10(5):3164-3173. doi: 10.1002/ehf2.14506. Epub 2023 Aug 30. PMID: 37649316; PMCID: PMC10567635.
• Gatti P, Linde C, Benson L, Thorvaldsen T, Normand C, Savarese G, Dahlström U, Maggioni AP, Dickstein K, Lund LH. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II. Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):741-748. doi: 10.1093/ehjqcco/qcad024. PMID: 37076773; PMCID: PMC10745247.
• Dewan P, Ferreira JP, Butt JH, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, Stewart S, Swedberg K, Zile MR, Solomon SD, Jhund PS, McMurray JJV. Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2023 May;25(5):687-697. doi: 10.1002/ejhf.2856. Epub 2023 Apr 24. PMID: 37062869.
• de Koning MLY, Emmens JE, Romero-Hernández E, Bourgonje AR, Assa S, Figarska SM, Cleland JGF, Samani NJ, Ng LL, Lang CC, Metra M, Filippatos GS, van Veldhuisen DJ, Anker SD, Dickstein K, Voors AA, Lipsic E, van Goor H, van der Harst P. Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. Clin Res Cardiol. 2023 Aug;112(8):1056-1066. doi: 10.1007/s00392-023-02171-x. Epub 2023 Mar 30. PMID: 36997667; PMCID: PMC10062262.
• Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann CE, Bistola V, Dahlstrom U, Dickstein K, Ertl G, Ghadanfar M, Hassanein M, Obergfell A, Perrone SV, Polyzogopoulou E, Schweizer A, Boletis I, Cleland JGF, Collins SP, Lam CSP, Filippatos G. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. Eur J Heart Fail. 2023 Jun;25(6):818-828. doi: 10.1002/ejhf.2833. Epub 2023 Apr 12. PMID: 36974770.
• Markousis-Mavrogenis G, Minich WB, Al-Mubarak AA, Anker SD, Cleland JGF, Dickstein K, Lang CC, Ng LL, Samani NJ, Zannad F, Metra M, Seemann P, Hoeg A, Lopez P, van Veldhuisen DJ, de Boer RA, Voors AA, van der Meer P, Schomburg L, Bomer N; BIOSTAT-CHF Consortium. Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. Cardiovasc Res. 2023 Jul 6;119(8):1690-1705. doi: 10.1093/cvr/cvad042. PMID: 36883593; PMCID: PMC10325696.
• Streng KW, Hillege HL, Ter Maaten JM, van Veldhuisen DJ, Dickstein K, Samani NJ, Ng LL, Metra M, Filippatos GS, Ponikowski P, Zannad F, Anker SD, van der Meer P, Lang CC, Voors AA, Damman K. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction. J Cardiovasc Transl Res. 2023 Feb 16. doi: 10.1007/s12265-023-10356-y. Epub ahead of print. PMID: 36795286.
• Weening EH, Al-Mubarak AA, Dokter MM, Dickstein K, Lang CC, Ng LL, Metra M, van Veldhuisen DJ, Touw DJ, de Boer RA, Gansevoort RT, Voors AA, Bakker SJL, van der Meer P, Bomer N. Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease. Cardiovasc Diabetol. 2023 Jan 12;22(1):8. doi: 10.1186/s12933-022-01730-2. PMID: 36635707; PMCID: PMC9838024.
• van der Hoef CCS, Boorsma EM, Emmens JE, van Essen BJ, Metra M, Ng LL, Anker SD, Dickstein K, Mordi IR, Dihoum A, Lang CC, van Veldhuisen DJ, Lam CSP, Voors AA. Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome. Eur J Heart Fail. 2023 Feb;25(2):163-173. doi: 10.1002/ejhf.2760. Epub 2023 Jan 16. PMID: 36597718.
• Gerstein HC, Wolsk E, Claggett B, Diaz R, Dickstein K, Hess S, Køber L, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Tardif JC, Pfeffer MA. Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes Obes Metab. 2023 Apr;25(4):1125-1129. doi: 10.1111/dom.14954. Epub 2023 Jan 3. PMID: 36546588.
• Ouwerkerk W, Tromp J, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Filippatos G, Collins SP, Lam CSP. Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail. 2023 Jan;25(1):43-51. doi: 10.1002/ejhf.2708. Epub 2022 Nov 23. PMID: 36196060; PMCID: PMC10099670.
• Boorsma EM, Ter Maaten JM, Damman K, van Essen BJ, Zannad F, van Veldhuisen DJ, Samani NJ, Dickstein K, Metra M, Filippatos G, Lang CC, Ng L, Anker SD, Cleland JG, Pellicori P, Gansevoort RT, Heerspink HJL, Voors AA, Emmens JE. Albuminuria as a marker of systemic congestion in patients with heart failure. Eur Heart J. 2023 Feb 1;44(5):368-380. doi: 10.1093/eurheartj/ehac528. PMID: 36148485; PMCID: PMC9890244.

• Alnuwaysir RIS, Grote Beverborg N, Hoes MF, Markousis-Mavrogenis G, Gomez KA, van der Wal HH, Cleland JGF, Dickstein K, Lang CC, Ng LL, Ponikowski P, Anker SD, van Veldhuisen DJ, Voors AA, van der Meer P. Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2022 Jan;24(1):192-204.

 

 

• Cooper TJ, Cleland JGF, Guazzi M, Pellicori P, Ben Gal T, Amir O, Al-Mohammad A, Clark AL, McConnachie A, Steine K, Dickstein K. Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial. Eur J Heart Fail. 2022 Jul;24(7):1239-1248.

 

• Baumhove L, Tromp J, Figarska S, van Essen BJ, Anker SD, Dickstein K, Cleland JG, Lang CC, Filippatos G, Ng LL, Samani NJ, Metra M, van Veldhuisen DJ, Lam CSP, Voors AA, van der Meer P. Heart failure with normal LVEF in BIOSTAT-CHF. Int J Cardiol. 2022 Oct 1;364:85-90.

 

• Santema BT, Arita VA, Sama IE, Kloosterman M, van den Berg MP, Nienhuis HLA, Van Gelder IC, van der Meer P, Zannad F, Metra M, Ter Maaten JM, Cleland JG, Ng LL, Anker SD, Lang CC, Samani NJ, Dickstein K, Filippatos G, van Veldhuisen DJ, Lam CSP, Rienstra M, Voors AA. Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovasc Res. 2022 Aug 24;118(11):2478-2487.

 

• Ravera A, Santema BT, de Boer RA, Anker SD, Samani NJ, Lang CC, Ng L, Cleland JGF, Dickstein K, Lam CSP, Van Spall HGC, Filippatos G, van Veldhuisen DJ, Metra M, Voors AA, Sama IE.Distinct pathophysiological pathways in women and men with heart failure. Eur J Heart Fail. 2022 Sep;24(9):1532-1544.

 

• Boorsma EM, Ter Maaten JM, Damman K, van Essen BJ, Zannad F, van Veldhuisen DJ, Samani NJ, Dickstein K, Metra M, Filippatos G, Lang CC, Ng L, Anker SD, Cleland JG, Pellicori P, Gansevoort RT, Heerspink HJL, Voors AA, Emmens JE.Albuminuria as a marker of systemic congestion in patients with heart failure. Eur Heart J. 2022 Sep 23:ehac528.

 

• Pandhi P, Ter Maaten JM, Anker SD, Ng LL, Metra M, Samani NJ, Lang CC, Dickstein K, de Boer RA, van Veldhuisen DJ, Voors AA, Sama IE.Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure. JACC Heart Fail. 2022 Sep;10(9):623-632.

 

• Tromp J, Ouwerkerk W, Cleland JGF, Chandramouli C, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Collins SP, Filippatos G, Lam CS.A global perspective of racial differences and outcomes in patients presenting with acute heart failure. Am Heart J. 2022 Jan;243:11-14.

 

• Streng KW, Hillege HL, Ter Maaten JM, van Veldhuisen DJ, Dickstein K, Ng LL, Samani NJ, Metra M, Ponikowski P, Cleland JG, Anker SD, Romaine SPR, Damman K, van der Meer P, Lang CC, Voors AA.Clinical implications of low estimated protein intake in patients with heart failure. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1762-1770.

 

• Kondo T, Abdul-Rahim AH, Talebi A, Abraham WT, Desai AS, Dickstein K, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Packer M, Petrie M, Ponikowski P, Rouleau JL, Sabatine MS, Swedberg K, Zile MR, Solomon SD, Jhund PS, McMurray JJV.Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. Eur Heart J. 2022 Nov 7;43(42):4469-4479.

 

• Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Ferreira JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Samani NJ; BIOSTAT-CHF Consortium; de Boer RA, van Veldhuisen DJ, Voors AA, van der Meer P. Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovasc Res. 2022 Jun 29;118(8):1964-1977.

 

• Ouwerkerk W, Tromp J, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Filippatos G, Collins SP, Lam CS.Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail. 2022 Oct 4.

 

• Emmens JE, de Borst MH, Boorsma EM, Damman K, Navis G, van Veldhuisen DJ, Dickstein K, Anker SD, Lang CC, Filippatos G, Metra M, Samani NJ, Ponikowski P, Ng LL, Voors AA, Ter Maaten JM.Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure.Clin J Am Soc Nephrol. 2022 Feb;17(2):228-239.

 

• Bracun V, van Essen B, Voors AA, van Veldhuisen DJ, Dickstein K, Zannad F, Metra M, Anker S, Samani NJ, Ponikowski P, Filippatos G, Cleland JGF, Lang CC, Ng LL, Shi C, de Wit S, Aboumsallem JP, Meijers WC, Klip IT, van der Meer P, de Boer RA.Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Fail. 2022 Dec;9(6):4167-4176.

 

• Savarese G, Uijl A, Ouwerkerk W, Tromp J, Anker SD, Dickstein K, Hage C, Lam CSP, Lang CC, Metra M, Ng LL, Orsini N, Samani NJ, van Veldhuisen DJ, Cleland JGF, Voors AA, Lund LH Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction. ESC Heart Fail. 2022 Aug;9(4):2107-2118.

 

• Pagnesi M, Adamo M, Sama IE, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Inciardi RM, Lang CC, Lombardi CM, Ng LL, Ponikowski P, Samani NJ, Zannad F, van Veldhuisen DJ, Voors AA, Metra M.Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure. Clin Res Cardiol. 2022 Aug;111(8):912-923.

 

• Curtain JP, Campbell RT, Petrie MC, Jackson AM, Abraham WT, Desai AS, Dickstein K, Køber L, Rouleau JL, Swedberg K, Zile MR, Solomon SD, Jhund PS, McMurray JJV. Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF. JACC Heart Fail. 2022 Jun;10(6):415-427.

 

• Tromp J, Beusekamp JC, Ouwerkerk W, van der Meer P, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Dickstein K, Collins SP, Lam CSP.Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. Eur J Heart Fail. 2022 Apr;24(4):645-652.

 

• Ceelen D, Voors AA, Tromp J, van Veldhuisen DJ, Dickstein K, de Boer RA, Lang CC, Anker SD, Ng LL, Metra M, Ponikowski P, Figarska SM.Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure. Eur J Heart Fail. 2022 Feb;24(2):308-320.

 

• Cooper TJ, Pellicori P, Ushakova A, Dickstein K.Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'. Eur J Heart Fail. 2022 Oct;24(10):1990-1992.

 

• Gerstein HC, Wolsk E, Claggett B, Diaz R, Dickstein K, Hess S, Køber L, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Tardif JC, Pfeffer MA.Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes Obes Metab. 2022 Dec 22.

 

• Gerstein HC, Hess S, Claggett B, Dickstein K, Kober L, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Tardif JC, Pfeffer MA.Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study. Diabetes Care. 2022 Sep 1;45(9):2152-2155.

 

• Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure. Inciardi RM, Pagnesi M, Lombardi CM, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Lang CC, Ng LL, Pellicori P, Ponikowski P, Samani NJ, Zannad F, van Veldhuisen DJ, Solomon SD, Voors AA, Metra M. Eur J Heart Fail. 2022 Nov;24(11):2131-2139.

 

• Koçyiğit D, Sarıgül NU, Altın T, Çay S, Normand C, Linde C, Dickstein K, Investigators CS. Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish Population. Turk Kardiyol Dern Ars. 2022 Apr;50(3):182-191.

 

• McNaughton CD, McConnachie A, Cleland JG, Spertus JA, Angermann CE, Duklas P, Tromp J, Lam CSP, Filippatos G, Dahlstrom U, Dickstein K, Schweizer A, Perrone SV, Hassanein M, Ertl G, Obergfell A, Ghadanfar M, Collins SP. Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). Eur J Heart Fail. 2022 Jun;24(6):1020-1029.

 

• Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N. The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction. J Womens Health (Larchmt). 2022 Mar;31(3):310-320.

 

• Wolsk E, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber L, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA. Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes. J Am Heart Assoc. 2022 Apr 19;11(8):e021327

 

• Laastad Sørensen M, Oterhals K, Pönitz V, Morken IM Point-of-care examinations using handheld ultrasound devices performed by intensive care nurses in a cardiac intensive care unit. .Eur J Cardiovasc Nurs. 2022 Sep 23:zvac089.

 

• Dhar I, Svingen GF, Pedersen EK, Ulvik A, Bjørnestad EØ, Dankel SN, Mellgren G, Nygård OK Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment. Int J Cardiol Cardiovasc Risk Prev. 2022 Sep 16;15:200150.

 

• Andersen T, Ueland T, Aukrust P, Nilsen DW, Grundt H, Staines H, Kontny F. Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes. Front Cardiovasc Med. 2022 May 20;9:867944.

 

• Bjørnestad EØ, Dhar I, Svingen GFT, Pedersen ER, Svenningsson MM, Tell GS, Ueland PM, Ørn S, Sulo G, Laaksonen R, Nygård O. Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease.Eur Heart J Open. 2021 Jul 16;1(1):oeab007

 

• Bjørnestad EØ, Dhar I, Svingen GFT, Pedersen ER, Ørn S, Svenningsson MM, Tell GS, Ueland PM, Sulo G, Laaksonen R, Nygård O. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. J Intern Med. 2022 Dec;292(6):915-924.

 

• González A, Haugaa KH, Brekke PH, Hopp E, Ørn S, Alvestad S, Taubøll E, Aurlien D.Cardiac Structure and Function in Epilepsy Patients with Drug-Resistant Convulsive Seizures. Case Rep Neurol. 2022 Mar 10;14(1):88-97.

 

• Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N.The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction. J Womens Health (Larchmt). 2022 Mar;31(3):310-320.

 

• Petersen Hella MN, Fagereng K, Kleiven Ø Trombe på tur. Tidsskriftet april 2022.. DOI: 10.4045/tidsskr.21.0651

 

• Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. J Intern Med. 2022 May;291(5):637-647. doi: 10.1111/joim.13442. Epub 2022 Jan 4.PMID: 34982486 Clinical Trial.

 

• Nilsen DWT, Røysland M, Ueland T, Aukrust P, Michelsen AE, Staines H, Barvik S, Kontny F, Nordrehaug JE, Bonarjee VVS. The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thromb Haemost. 2022 Dec 31. Saeed N, Norekvål TM, Steiro OT, Tjora HL, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Omland T, Vikenes K, Aakre KM. Predictors of long-term symptom burden and quality of life in patients hospitalised with chest pain: a prospective observational study. BMJ Open. 2022 Jul 13;12(7):e062302.

 

• Steiro OT, Aakre KM, Tjora HL, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Omland T, Vikenes K, Langørgen J.Association between symptoms and risk of non-ST segment elevation myocardial infarction according to age and sex in patients admitted to the emergency department with suspected acute coronary syndrome: a single-centre retrospective cohort study. BMJ Open. 2022 May 12;12(5):e054185. doi: 10.1136/bmjopen-2021-054185.PMID: 35551077 Free PMC article.

 

• Tjora HL, Steiro OT, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Collinson P, Omland T, Vikenes K, Aakre KM.Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2022 Feb 1;68(2):291-302.

 

• Restan IZ, Sanchez AY, Steiro OT, Lopez-Ayala P, Tjora HL, Langørgen J, Omland T, Boeddinghaus J, Nestelberger T, Koechlin L, Collinson P, Bjørneklett R, Vikenes K, Strand H, Skadberg Ø, Mjelva ØR, Larsen AI, Bonarjee VVS, Mueller C, Aakre KM.Adding stress biomarkers to high-sensitivity cardiac troponin for rapid non-ST-elevation myocardial infarction rule-out protocols. Eur Heart J Acute Cardiovasc Care. 2022 Mar 16;11(3):201-212.

 

• Pettersen TR, Schjøtt J, Allore HG, Bendz B, Borregaard B, Fridlund B, Larsen AI, Nordrehaug JE, Rotevatn S, Wentzel-Larsen T, Norekvål TM. Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study. BMJ Open. 2022 Sep 20;12(9):e061689.

 

• Røysland IØ, Ueland VI, Larsen AI. Reassured on a background of vulnerability - people with microvascular angina 12 months after high-intensity physical exercise program. Int J Qual Stud Health Well-being. 2023 Dec;18(1):2162452.

 

• Gyldenkerne C, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Erik Bøtker H, Engstrøm T, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Rosen HC, Stone GW, Erlinge D. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II. Circulation. 2023 Feb 7;147(6):469-481. Epub 2022 Dec 16.PMID: 36524476

 

• Larsen AI, Løland KH, Hovland S, Bleie Ø, Eek C, Fossum E, Trovik T, Juliebø V, Hegbom K, Moer R, Larsen T, Uchto M, Rotevatn S.Guideline-Recommended Time Less Than 90 Minutes From ECG to Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Is Associated with Major Survival Benefits, Especially in Octogenarians: A Contemporary Report in 11 226 Patients from NORIC. J Am Heart Assoc. 2022 Sep 6;11(17):e024849. doi: 10.1161/JAHA.122.024849.

 

• Larsen AI, Fearon WF, Anderson TJ, Pijls N. Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure. J Interv Cardiol. 2022 Jan 26;2022:9846391.

 

• Larsen AI, Grejs AM, Vistisen ST, Strand K, Skadberg Ø, Jeppesen AN, Duez CHV, Kirkegaard H, Søreide E. Kinetics of 2 different high-sensitive troponins during targeted temperature management in out-of-hospital cardiac arrest patients with acute myocardial infarction: a post hoc sub-study of a randomised clinical trial. BMC Cardiovasc Disord. 2022 Jul 30;22(1):342.

 

• Sourour N, Riveland E, Rømo T, Naesgaard P, Kjekshus H, Larsen AI, Omland T, Røsjø H, Myhre PL.QRS fragmentation is associated with increased risk of ventricular arrhythmias in high-risk patients; Data from the SMASH 1 Study. Ann Noninvasive Electrocardiol. 2022 Sep;27(5):e12985.

 

• Fearon WF, Zimmermann FM, De Bruyne B, Piroth Z, van Straten AHM, Szekely L, Davidavičius G, Kalinauskas G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Aminian A, Oldroyd KG, Al-Attar N, Jagic N, Dambrink JE, Kala P, Angerås O, MacCarthy P, Wendler O, Casselman F, Witt N, Mavromatis K, Miner SES, Sarma J, Engstrøm T, Christiansen EH, Tonino PAL, Reardon MJ, Lu D, Ding VY, Kobayashi Y, Hlatky MA, Mahaffey KW, Desai M, Woo YJ, Yeung AC, Pijls NHJ, (Larsen AI); FAME 3 Investigators. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.N Engl J Med. 2022 Jan 13;386(2):128-137.

• Tjora HL, Steiro OT, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Collinson P, Omland T, Vikenes K, Aakre KM. Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2021 Dec 13:hvab225. doi: 10.1093/clinchem/hvab225. Epub ahead of print. PMID: 34897415.

 

• Steiro OT, Tjora HL, Langørgen J, Bjørneklett R, Nygård OK, Skadberg Ø, Bonarjee VVS, Lindahl B, Omland T, Vikenes K, Aakre KM. Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study. Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):287-301. doi: 10.1093/ehjacc/zuaa016. PMID: 33620429.

 

 

 

• Alnuwaysir RIS, Grote Beverborg N, Hoes MF, Markousis-Mavrogenis G, Gomez KA, van der Wal HH, Cleland JGF, Dickstein K, Lang CC, Ng LL, Ponikowski P, Anker SD, van Veldhuisen DJ, Voors AA, van der Meer P. Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2021 Nov 23. doi: 10.1002/ejhf.2393. Epub ahead of print. PMID: 34816550.

 

• Santema BT, Arita VA, Sama IE, Kloosterman M, van den Berg MP, Nienhuis HLA, Van Gelder IC, van der Meer P, Zannad F, Metra M, Ter Maaten JM, Cleland JG, Ng LL, Anker SD, Lang CC, Samani NJ, Dickstein K, Filippatos G, van Veldhuisen DJ, Lam CSP, Rienstra M, Voors AA. Pathophysiological pathways in patients with heart failure and atrial fibrillation. Cardiovasc Res. 2021 Oct 23:cvab331. doi: 10.1093/cvr/cvab331. Epub ahead of print. PMID: 34687289.

 

• Tromp J, Ouwerkerk W, Cleland JGF, Chandramouli C, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Collins SP, Filippatos G, Lam CS. A global perspective of racial differences and outcomes in patients presenting with acute heart failure. Am Heart J. 2022 Jan;243:11-14. doi: 10.1016/j.ahj.2021.09.001. Epub 2021 Sep 10. PMID: 34516969.

 

• Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Fereirra JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Samani NJ; BIOSTAT-CHF Consortium, de Boer RA, van Veldhuisen DJ, Voors AA, van der Meer P. Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovasc Res. 2021 Jul 15:cvab235. doi: 10.1093/cvr/cvab235. Epub ahead of print. PMID: 34264317.

 

• Pagnesi M, Adamo M, Sama IE, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Lang CC, Ng LL, Ponikowski P, Ravera A, Samani NJ, Zannad F, van Veldhuisen DJ, Voors AA, Metra M. Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. Eur J Heart Fail. 2021 Oct;23(10):1750-1758. doi: 10.1002/ejhf.2276. Epub 2021 Aug 1. PMID: 34164895.

 

• Shen L, Claggett BL, Jhund PS, Abraham WT, Desai AS, Dickstein K, Gong J, Køber LV, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, McMurray JJV. Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clin Res Cardiol. 2021 Aug;110(8):1334-1349. doi: 10.1007/s00392-021-01888-x. Epub 2021 Jun 8. PMID: 34101002; PMCID: PMC8318968.

 

• Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund LH, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Nielsen JC, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace. 2021 Aug 6;23(8):1324-1342. doi: 10.1093/europace/euaa411. PMID: 34037728.

 

• Curran FM, Bhalraam U, Mohan M, Singh JS, Anker SD, Dickstein K, Doney AS, Filippatos G, George J, Metra M, Ng LL, Palmer CN, Samani NJ, van Veldhuisen DJ, Voors AA, Lang CC, Mordi IR. Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021 Aug;8(4):3168-3179. doi: 10.1002/ehf2.13424. Epub 2021 May 16. PMID: 33998162; PMCID: PMC8318449.

 

• Kobayashi M, Voors AA, Ouwerkerk W, Duarte K, Girerd N, Rossignol P, Metra M, Lang CC, Ng LL, Filippatos G, Dickstein K, van Veldhuisen DJ, Zannad F, Ferreira JP. Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure. Clin Cardiol. 2021 Jun;44(6):780-788. doi: 10.1002/clc.23576. Epub 2021 May 7. PMID: 33960439; PMCID: PMC8207977.

 

• Emmens JE, Jia C, Ng LL, van Veldhuisen DJ, Dickstein K, Anker SD, Lang CC, Filippatos G, Cleland JGF, Metra M, Voors AA, de Boer RA, Tietge UJF. Impaired High-Density Lipoprotein Function in Patients With Heart Failure. J Am Heart Assoc. 2021 May 4;10(9):e019123. doi: 10.1161/JAHA.120.019123. Epub 2021 Apr 17. PMID: 33870728; PMCID: PMC8200730.

 

• Tromp J, Ouwerkerk W, Cleland JGF, Angermann CE, Dahlstrom U, Tiew-Hwa Teng K, Bamadhaj S, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Collins SP, Lam CSP, Dickstein K. Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. JACC Heart Fail. 2021 May;9(5):349-359. doi: 10.1016/j.jchf.2020.12.015. Epub 2021 Apr 7. PMID: 33839078.

 

• Gupta P, Voors AA, Patel P, Lane D, Anker SD, Cleland JGF, Dickstein K, Filippatos G, Lang CC, van Veldhuisen DJ, Metra M, Zannad F, Samani NJ, Jones DJL, Squire IB, Ng LL. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). Eur J Heart Fail. 2021 Jul;23(7):1182-1190. doi: 10.1002/ejhf.2160. Epub 2021 May 3. PMID: 33759308.

 

• Boorsma EM, Ter Maaten JM, Damman K, van Veldhuisen DJ, Dickstein K, Anker SD, Filippatos G, Lang CC, Metra M, Santos K, Voors AA. Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure. Eur J Heart Fail. 2021 Jun;23(6):947-953. doi: 10.1002/ejhf.2158. Epub 2021 Mar 30. PMID: 33742751; PMCID: PMC8359955.

 

• Pandhi P, Streng KW, Anker SD, Cleland JG, Damman K, Dickstein K, Pellicori P, Lang CC, Ng L, Samani NJ, Zannad F, Metra M, Rossignol P, Filippatos G, van Veldhuisen DJ, Voors AA, Ter Maaten JM. The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):555-567. doi: 10.1002/jcsm.12690. Epub 2021 Mar 20. PMID: 33742549; PMCID: PMC8200450.

 

• Ravera A, Santema BT, Sama IE, Meyer S, Lombardi CM, Carubelli V, Ferreira JP, Lang CC, Dickstein K, Anker SD, Samani NJ, Zannad F, van Veldhuisen DJ, Teerlink JR, Metra M, Voors AA. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire. Eur J Heart Fail. 2021 Apr;23(4):567-577. doi: 10.1002/ejhf.2154. Epub 2021 May 4. PMID: 33728762; PMCID: PMC8252457.

 

• Woolley RJ, Ceelen D, Ouwerkerk W, Tromp J, Figarska SM, Anker SD, Dickstein K, Filippatos G, Zannad F, Metra M, Ng L, Samani N, van Veldhuisen DJ, Lang C, Lam CS, Voors AA. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail. 2021 Jun;23(6):983-991. doi: 10.1002/ejhf.2144. Epub 2021 Mar 17. Erratum in: Eur J Heart Fail. 2021 Oct;23(10):1802. PMID: 33651430; PMCID: PMC8360080.

 

• Khan MS, Kristensen SL, Vaduganathan M, Kober L, Abraham WT, Desai AS, Solomon SD, Swedberg K, Dickstein K, Zile MR, Packer M, McMurray JJ, Butler J. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. Am Heart J. 2021 Jul;237:45-53. doi: 10.1016/j.ahj.2021.02.015. Epub 2021 Feb 20. PMID: 33621540.

 

• Hui SK, Sharma A, Docherty K, McMurray JJV, Pitt B, Dickstein K, Pfeffer MA, Girerd N, Rossignol P, Ferreira JP, Zannad F. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):127-131. doi: 10.1093/ehjacc/zuaa012. PMID: 33620418.

 

• Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund L, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Cosedis Nielsen J, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care. Europace. 2021 Feb 5:euab035. doi: 10.1093/europace/euab035. Epub ahead of print. PMID: 33544835.

 

• Davison BA, Senger S, Sama IE, Koch GG, Mebazaa A, Dickstein K, Samani NJ, Metra M, Anker SD, Cleland JG, Ng LL, Mordi IR, Zannad F, Filippatos GS, Hillege HL, Ponikowski P, van Veldhuisen DJ, Lang CC, van der Meer P, Núñez J, Bayés-Genís A, Edwards C, Voors AA, Cotter G. Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF. Eur J Heart Fail. 2021 Jan;23(1):43-57. doi: 10.1002/ejhf.2077. Epub 2021 Jan 22. PMID: 33340221.

 

• Koçyiğit D, Sarıgül NU, Altın AT, Çay S, Polat V, Saygı S, Gümrükçüoğlu HA, Gemici K, İkitimur B, Akyol A, Bilge AK, Başarıcı İ, Özcan EE, Demir M, Kabul HK, Ornek E, Normand C, Linde C, Dickstein K. Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II. Anatol J Cardiol. 2020 Dec;24(6):382-396. doi: 10.14744/AnatolJCardiol.2020.02680. PMID: 33253125; PMCID: PMC7791302.

 

• Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP, Mamas MA, Clark AL, Edelmann F, Pieske B, Khan J, McDonald K, Rouet P, Staessen JA, Mujaj B, González A, Diez J, Hazebroek M, Heymans S, Latini R, Grojean S, Pizard A, Girerd N, Rossignol P, Collier TJ, Zannad F; HOMAGE Trial Committees and Investigators. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. Eur Heart J. 2021 Feb 11;42(6):684-696. doi: 10.1093/eurheartj/ehaa758. PMID: 33215209; PMCID: PMC7878013.

 

• Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter Maaten JM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA. Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. 2021 Aug;110(8):1351. doi: 10.1007/s00392-020-01762-2. Erratum for: Clin Res Cardiol. 2020 Mar;109(3):331-338. PMID: 33141252; PMCID: PMC8318930.

 

 

 

• Mecinaj A, Gulati G, Heck SL, Holte E, Fagerland MW, Larsen AI, Blix ES, Geisler J, Wethal T, Omland T. Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial. Cardiooncology. 2021 Sep 27;7(1):33. doi: 10.1186/s40959-021-00115-w. PMID: 34579775; PMCID: PMC8474901.

 

• Valborgland T, Isaksen K, Munk PS, Larsen AI. Blood Lactate AUC Is a Sensitive Test for Evaluating the Effect of Exercise Training on Functional Work Capacity in Patients with Chronic Heart Failure. Rehabil Res Pract. 2021 Sep 30;2021:6619747. doi: 10.1155/2021/6619747. PMID: 34631167; PMCID: PMC8497121.

 

• Bergland AK, Soennesyn H, Dalen I, Rodriguez-Mateos A, Berge RK, Giil LM, Rajendran L, Siow R, Tassotti M, Larsen AI, Aarsland D. Corrigendum: Effects of Anthocyanin Supplementation on Serum Lipids, Glucose, Markers of Inflammation and Cognition in Adults With Increased Risk of Dementia - A Pilot Study. Front Genet. 2021 May 31;12:678504. doi: 10.3389/fgene.2021.678504. Erratum for: Front Genet. 2019 Jun 11;10:536. PMID: 34135944; PMCID: PMC8202680.

 

• Koppen E, Omland T, Larsen AI, Karlsen T, Linke A, Prescott E, Halle M, Dalen H, Delagardelle C, Hole T, van Craenenbroeck EM, Beckers P, Ellingsen Ø, Feiereisen P, Valborgland T, Videm V; SMARTEX-HF Study Group. Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2021 Jun;8(3):2183-2192. doi: 10.1002/ehf2.13310. Epub 2021 Mar 23. PMID: 33754453; PMCID: PMC8120390.

 

• Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X. PMID: 33714389.

 

• Nordfonn OK, Morken IM, Bru LE, Larsen AI, Husebø AML. Burden of treatment in patients with chronic heart failure - A cross-sectional study. Heart Lung. 2021 May-Jun;50(3):369-374. doi: 10.1016/j.hrtlng.2021.02.003. Epub 2021 Feb 20. PMID: 33618147.

 

• Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H; OMEMI Investigators. Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial. Circulation. 2021 Feb 9;143(6):528-539. doi: 10.1161/CIRCULATIONAHA.120.052209. Epub 2020 Nov 15. PMID: 33191772.

 

• Samuelsen PJ, Eggen AE, Steigen T, Wilsgaard T, Kristensen A, Skogsholm A, Holme E, van den Heuvel C, Nordrehaug JE, Bendz B, Nilsen DWT, Bønaa KH. Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT). PLoS One. 2021 Mar 4;16(3):e0247358. doi: 10.1371/journal.pone.0247358. PMID: 33661918; PMCID: PMC7932162.

 

• Aarsetøy R, Ten Cate H, Spronk H, Van Oerle R, Aarsetøy H, Staines H, Nilsen DWT. Activated factor XI-antithrombin complex presenting as an independent predictor of 30-days mortality in out-of-hospital cardiac arrest patients. Thromb Res. 2021 Aug;204:1-8. doi: 10.1016/j.thromres.2021.05.014. Epub 2021 May 29. PMID: 34089982.

 

• Aarsetøy R, Ueland T, Aukrust P, Michelsen AE, de la Fuente RL, Pönitz V, Brügger-Andersen T, Grundt H, Staines H, Nilsen DWT. Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. J Intern Med. 2021 Oct;290(4):894-909. doi: 10.1111/joim.13339. Epub 2021 Jul 8. PMID: 34237166.

 

• Aarsetøy R, Ueland T, Aukrust P, Michelsen AE, Leon de la Fuente R, Grundt H, Staines H, Nygaard O, Nilsen DWT. Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome. BMC Cardiovasc Disord. 2021 Oct 14;21(1):496. doi: 10.1186/s12872-021-02306-w. PMID: 34649504; PMCID: PMC8515738.

 

• Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I. Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction. Nutrients. 2021 Sep 30;13(10):3475. doi: 10.3390/nu13103475. PMID: 34684479; PMCID: PMC8540726.

 

• Frøysa V, Berg GJ, Eftestøl T, Woie L, Ørn S. Texture-based probability mapping for automatic scar assessment in late gadolinium-enhanced cardiovascular magnetic resonance images. Eur J Radiol Open. 2021 Dec 3;8:100387. doi: 10.1016/j.ejro.2021.100387. PMID: 34926726; PMCID: PMC8649215.

 

• Aengevaeren VL, Baggish AL, Chung EH, George K, Kleiven Ø, Mingels AMA, Ørn S, Shave RE, Thompson PD, Eijsvogels TMH. Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance. Circulation. 2021 Dec 14;144(24):1955-1972. doi: 10.1161/CIRCULATIONAHA.121.056208. Epub 2021 Dec 13. PMID: 34898243; PMCID: PMC8663527.

 

• Bjørkavoll-Bergseth M, Erevik CB, Kleiven Ø, Eijsvogels TMH, Skadberg Ø, Frøysa V, Wiktorski T, Auestad B, Edvardsen T, Moberg Aakre K, Ørn S. Determinants of Interindividual Variation in Exercise-Induced Cardiac Troponin I Levels. J Am Heart Assoc. 2021 Sep 7;10(17):e021710. doi: 10.1161/JAHA.121.021710. Epub 2021 Aug 28. PMID: 34459237.

 

• Hansen MW, Ørn S, Erevik CB, Bjørkavoll-Bergseth MF, Skadberg Ø, Melberg TH, Aakre KM, Kleiven Ø. Regular consumption of cod liver oil is associated with reduced basal and exercise-induced C-reactive protein levels; a prospective observational trial : A NEEDED (The North Sea Race Endurance Exercise Study) 2014 sub-study. J Int Soc Sports Nutr. 2021 Jun 28;18(1):51. doi: 10.1186/s12970-021-00437-1. PMID: 34183020; PMCID: PMC8240263.

 

• Thorsen IS, Gøransson LG, Ueland T, Aukrust P, Manhenke CA, Skadberg Ø, Jonsson G, Ørn S. The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI. Int J Cardiol Heart Vasc. 2021 Feb 19;33:100727. doi: 10.1016/j.ijcha.2021.100727. PMID: 33665349; PMCID: PMC7905449.

 

• Bjørnestad EØ, Dhar I, Svingen GFT, Pedersen ER, Svenningsson MM, Tell GS, Ueland PM, Ørn S, Sulo G, Laaksonen R, Nygård O, Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease, European Heart Journal Open, Volume 1, Issue 1, August 2021, oeab007, https://doi.org/10.1093/ehjopen/oeab007

• Sama IE, Woolley RJ, Nauta JF, Romaine SPR, Tromp J, Ter Maaten JM, van der Meer P, Lam CSP, Samani NJ, Ng LL, Metra M, Dickstein K, Anker SD, Zannad F, Lang CC, Cleland JGF, van Veldhuisen DJ, Hillege HL, Voors AAA network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure. Eur J Heart Fail. 2020 May;22(5):821-833. doi: 10.1002/ejhf.1811. Epub 2020 Apr 3.PMID: 32243695

 

• Filippatos G, Angermann CE, Cleland JGF, Lam CSP, Dahlström U, Dickstein K, Ertl G, Hassanein M, Hart KW, Lindsell CJ, Perrone SV, Guerin T, Ghadanfar M, Schweizer A, Obergfell A, Collins SP.Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure. JAMA Cardiol. 2020 Apr 1;5(4):401-410. doi: 10.1001/jamacardio.2019.5108.PMID: 31913404

 

• Docherty KF, Ferreira JP, Sharma A, Girerd N, Gregson J, Duarte K, Petrie MC, Jhund PS, Dickstein K, Pfeffer MA, Pitt B, Rossignol P, Zannad F, McMurray JJV.Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. Eur J Heart Fail. 2020 May;22(5):848-855. doi: 10.1002/ejhf.1694. Epub 2020 Jan 16.PMID: 31944496

 

• Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, Tay WT, Dickstein K, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Lam CSP, Filippatos G, Collins SP.Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health. 2020 Mar;8(3):e411-e422. doi: 10.1016/S2214-109X(20)30004-8.PMID: 32087174

 

• Davison BA, Senger S, Sama IE, Koch GG, Mebazaa A, Dickstein K, Samani NJ, Metra M, Anker SD, Cleland JG, Ng LL, Mordi IR, Zannad F, Filippatos GS, Hillege HL, Ponikowski P, van Veldhuisen DJ, Lang CC, van der Meer P, Núñez J, Bayés-Genís A, Edwards C, Voors AA, Cotter G. Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF. Eur J Heart Fail. 2020 Dec 19. doi: 10.1002/ejhf.2077. Online ahead of print.PMID: 33340221

 

• Shi C, van der Wal HH, Silljé HHW, Dokter MM, van den Berg F, Huizinga L, Vriesema M, Post J, Anker SD, Cleland JG, Ng LL, Samani NJ, Dickstein K, Zannad F, Lang CC, van Haelst PL, Gietema JA, Metra M, Ameri P, Canepa M, van Veldhuisen DJ, Voors AA, de Boer RA. Tumour biomarkers: association with heart failure outcomes.J Intern Med. 2020 Aug;288(2):207-218. doi: 10.1111/joim.13053. Epub 2020 May 5.PMID: 32372544

 

• Israr MZ, Salzano A, Yazaki Y, Voors AA, Ouwerkerk W, Anker SD, Cleland JG, Dickstein K, Metra M, Samani NJ, Ng LL, Suzuki T; BIOSTAT-CHF Consortium (see Appendix). Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT-CHF. Eur J Heart Fail. 2020 Aug;22(8):1486-1490. doi: 10.1002/ejhf.1951. Epub 2020 Jul 30.PMID: 32666670 

 

• Gauthey A, Willems R, Vandekerckhove Y, Mullens W, Stefan L, Carryn X, Blommaert D, Mairesse G, Dickstein K, Normand C, Linde C, Le Polain de Waroux JB.
1. Benchmarking Belgian CRT practice against the rest of Europe: insights from the ESC-CRT survey II. Acta Cardiol. 2020 Oct;75(6):492-496. doi: 10.1080/00015385.2019.1621455. Epub 2019 Jun 13.PMID: 31190617

 

• Mordi IR, Ouwerkerk W, Anker SD, Cleland JG, Dickstein K, Metra M, Ng LL, Samani NJ, van Veldhuisen DJ, Zannad F, Voors AA, Lang CC. Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. Eur J Heart Fail. 2020 Mar 25. doi: 10.1002/ejhf.1799. Online ahead of print.PMID: 32216000

 

• Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter Maaten JM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. 2020 Mar;109(3):331-338. doi: 10.1007/s00392-019-01513-y. Epub 2019 Jul 1.PMID: 31263996

 

• Ferreira JP, Ouwerkerk W, Santema BT, van Veldhuisen DJ, Lang CC, Ng LL, Anker SD, Dickstein K, Metra M, Cleland JGF, Nilesh SJ, Filippatos G, Aboumsallem JP, de Boer RA, Figarska S, Sama IE, Voors AA, Zannad F. Differences in biomarkers and molecular pathways according to age for patients with HFrEF. Cardiovasc Res. 2020 Oct 1:cvaa279. doi: 10.1093/cvr/cvaa279. Online ahead of print.PMID: 33002110

 

• Al-Mubarak AA, Grote Beverborg N, Anker SD, Samani NJ, Dickstein K, Filippatos G, van Veldhuisen DJ, Voors AA, Bomer N, van der Meer P. A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure. 2020 Aug 21;12(9):2541. doi: 10.3390/nu12092541.PMID: 3282578

 

• Normand C, Linde C, Blomström-Lundqvist C, Stellbrink C, Gasparini M, Anker SD, Plummer C, Sarigul NU, Papiashvili G, Iovev S, Dickstein K. Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II. 2020 Jun 1;22(6):932-938. doi: 10.1093/europace/euaa067.PMID: 32330937

 

• Kobayashi M, Voors AA, Girerd N, Billotte M, Anker SD, Cleland JG, Lang CC, Ng LL, van Veldhuisen DJ, Dickstein K, Metra M, Duarte K, Rossignol P, Zannad F, Ferreira JP. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. Eur J Intern Med. 2020 Jan;71:62-69. doi: 10.1016/j.ejim.2019.10.017. Epub 2019 Nov 8.PMID: 3170836

 

• Kobayashi M, Stienen S, Ter Maaten JM, Dickstein K, Samani NJ, Lang CC, Ng LL, Anker SD, Metra M, Preud'homme G, Duarte K, Lamiral Z, Girerd N, Rossignol P, van Veldhuisen DJ, Voors AA, Zannad F, Ferreira JP. Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure. ESC Heart Fail. 2020 Jun;7(3):953-963. doi: 10.1002/ehf2.12634. Epub 2020 Mar 13.PMID: 32167681

 

• Botto GL, Gasparini M, Brasca FMA, Casale MC, Occhetta E, Racheli M, Bertaglia M, Zanon F, Zardini M, Rapacciuolo A, Mascioli G, Curnis A, Metra M, Normand C, Dickstein K, Linde C. Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort. J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):634-640. doi: 10.2459/JCM.0000000000001035.PMID: 32740496

 

• Koçyiğit D, Sarıgül NU, Altın AT, Çay S, Polat V, Saygı S, Gümrükçüoğlu HA, Gemici K, İkitimur B, Akyol A, Bilge AK, Başarıcı İ, Özcan EE, Demir M, Kabul HK, Ornek E, Normand C, Linde C, Dickstein K. Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II. Anatol J Cardiol. 2020 Dec;24(6):382-396. doi: 10.14744/AnatolJCardiol.2020.02680.PMID: 33253125

 

• Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund L, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Nielsen JC, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care. Eur J Heart Fail. 2020 Nov 2. doi: 10.1002/ejhf.2046. Online ahead of print.PMID: 33136300

 

• Jaarsma T, Klompstra L, Ben Gal T, Ben Avraham B, Boyne J, Bäck M, Chialà O, Dickstein K, Evangelista L, Hagenow A, Hoes AW, Hägglund E, Piepoli MF, Vellone E, Zuithoff NPA, Mårtensson J, Strömberg A. Effects of exergaming on exercise capacity in patients with heart failure: results of an international multicentre randomized controlled trial. Eur J Heart Fail. 2020 Mar 13. doi: 10.1002/ejhf.1754. Online ahead of print.PMID: 32167657

 

• Rossignol P, Duarte K, Girerd N, Karoui M, McMurray JJV, Swedberg K, van Veldhuisen DJ, Pocock S, Dickstein K, Zannad F, Pitt B. Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction.  Eur J Heart Fail. 2020 Aug;22(8):1402-1411. doi: 10.1002/ejhf.1724. Epub 2020 Jan 9.PMID: 31919958

 

• Lombardi CM, Ferreira JP, Carubelli V, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Voors A, Metra M. Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clin Res Cardiol. 2020 Aug;109(8):967-977. doi: 10.1007/s00392-019-01588-7. Epub 2020 Jan 29.PMID: 31996990

 

• Lawin D, Israel CW, Linde C, Normand C, Dickstein K, Lober C, Gitt AK, Hindricks G, Stellbrink C; members of the European CRT Survey II of the EHRA/HFA/ESC. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. Clin Res Cardiol. 2020 Jul;109(7):832-844. doi: 10.1007/s00392-019-01574-z. Epub 2019 Dec 6.PMID: 31811440

 

• Cao TH, Jones DJL, Voors AA, Quinn PA, Sandhu JK, Chan DCS, Parry HM, Mohan M, Mordi IR, Sama IE, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Metra M, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zannad F, Lang CC, Ng LL. Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets.Eur J Heart Fail. 2020 Jan;22(1):70-80. doi: 10.1002/ejhf.1608. Epub 2019 Nov 6.PMID: 31692186

 

• Nauta JF, Hummel YM, Tromp J, Ouwerkerk W, van der Meer P, Jin X, Lam CSP, Bax JJ, Metra M, Samani NJ, Ponikowski P, Dickstein K, Anker SD, Lang CC, Ng LL, Zannad F, Filippatos GS, van Veldhuisen DJ, van Melle JP, Voors AA. Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment. Eur J Heart Fail. 2020 Jul;22(7):1147-1155. doi: 10.1002/ejhf.1632. Epub 2019 Nov 11.PMID: 3171332

 

• Ferreira JP, Ouwerkerk W, Tromp J, Ng L, Dickstein K, Anker S, Filippatos G, Cleland JG, Metra M, van Veldhuisen DJ, Voors AA, Zannad F. Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2020 Jan;22(1):81-89. doi: 10.1002/ejhf.1654. Epub 2019 Dec 2.PMID: 31793144

 

• Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter Maaten JM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA. Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. 2020 Nov 3. doi: 10.1007/s00392-020-01762-2. Online ahead of print.PMID: 33141252

 

• Ranganathan D, Sharif Z, Murphy T, Mahon N, Sheahan CR, Normand C, Linde C, Dickstein K, Sheahan R. CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis.Ir J Med Sci. 2020 Aug;189(3):895-905. doi: 10.1007/s11845-020-02173-y. Epub 2020 Jan 24.PMID: 31981072

 

• Dewan P, Jackson A, Jhund PS, Shen L, Ferreira JP, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020 Nov;22(11):2123-2133. doi: 10.1002/ejhf.1832. Epub 2020 Apr 30.PMID: 32353205

 

• Nielsen JC, Kautzner J, Casado-Arroyo R, Burri H, Callens S, Cowie MR, Dickstein K, Drossart I, Geneste G, Erkin Z, Hyafil F, Kraus A, Kutyifa V, Marin E, Schulze C, Slotwiner D, Stein K, Zanero S, Heidbuchel H, Fraser AG. Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force report. 2020 Nov 1;22(11):1742-1758. doi: 10.1093/europace/euaa168.PMID: 32725140

 

• Ranganathan D, Sharif Z, Murphy T, Mahon N, Sheahan CR, Normand C, Linde C, Dickstein K, Sheahan R. Correction to: CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis. Ir J Med Sci. 2020 Aug;189(3):941. doi: 10.1007/s11845-020-02193-8.PMID: 32026269

 

• Ter Maaten JM, Martens P, Damman K, Dickstein K, Ponikowski P, Lang CC, Ng LL, Anker SD, Samani NJ, Filippatos G, Cleland JG, Zannad F, Hillege HL, van Veldhuisen DJ, Metra M, Voors AA, Mullens W. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clin Res Cardiol. 2020 Aug;109(8):1048-1059. doi: 10.1007/s00392-020-01598-w. Epub 2020 Jan 30.PMID: 32002631

 

• Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, Tay WT, Dickstein K, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Lam CS, Filippatos G, Collins SP. Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health. 2020 Aug;8(8):e1001. doi: 10.1016/S2214-109X(20)30294-1.PMID: 32710857

 

• Ouwerkerk W, Teng TK, Tromp J, Tay WT, Cleland JG, van Veldhuisen DJ, Dickstein K, Ng LL, Lang CC, Anker SD, Zannad F, Hung CL, Sawhney JPS, Naik A, Shimizu W, Hagiwara N, Wander GS, Anand I, Richards AM, Voors AA, Lam CSP. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries. Eur J Heart Fail. 2020 Aug;22(8):1472-1482. doi: 10.1002/ejhf.1869. Epub 2020 Jun 25.PMID: 3258392

 

• Shin SH, Claggett B, Pfeffer MA, Skali H, Liu J, Aguilar D, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Tardif JC, Solomon SD; ELIXA Investigators. Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. Eur J Heart Fail. 2020 Jul;22(7):1133-1143. doi: 10.1002/ejhf.1790. Epub 2020 Mar 25.PMID: 32212368

 

• Kristensen SL, Castagno D, Shen L, Jhund PS, Docherty KF, Rørth R, Abraham WT, Desai AS, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Committees and investigators.. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020 Jul 28. doi: 10.1002/ejhf.1972. Online ahead of print.PMID: 32720404

 

• Furtado RHM, Nicolau JC, Magnani G, Im K, Bhatt DL, Storey RF, Steg PG, Spinar J, Budaj A, Kontny F, Corbalan R, Kiss RG, Abola MT, Johanson P, Jensen EC, Braunwald E, Sabatine MS, Bonaca MP. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. Eur Heart J. 2020 May 1;41(17):1625-1632. doi: 10.1093/eurheartj/ehz821. PMID: 31811715. Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):294-302.

 

• Ueland T, Åkerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Budaj A, Cornel JH, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Atherosclerosis. 2020 Jan;293:35-41. doi: 10.1016/j.atherosclerosis.2019.11.031. Epub 2019 Nov 29. PMID: 31835039.

 

• Furtado RHM, Nicolau JC, Magnani G, Im K, Bhatt DL, Storey RF, Steg PG, Spinar J, Budaj A, Kontny F, Corbalan R, Kiss RG, Abola MT, Johanson P, Jensen EC, Braunwald E, Sabatine MS, Bonaca MP. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. Eur Heart J. 2020 May 1;41(17):1625-1632. doi: 10.1093/eurheartj/ehz821. PMID: 31811715.

 

• Larsen AI. The pulse; from adagio to prestissimo; the prognostic importance of heart rate increase and its associations with cardiovascular risk factors. Eur J Prev Cardiol. 2020;27(5):520-525.

 

• Khalifa K, Bergland AK, Soennesyn H, Oppedal K, Oesterhus R, Dalen I, Larsen AI, Fladby T, Brooker H, Wesnes KA, Ballard C, Aarsland D. Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial. Front Neurol. 2020 Sep 2;11:916.

 

• Windecker S, Latib A, Kedhi E, et al. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. N Engl J Med. 2020;382(13):1208-1218. 

 

• Norekvål, T. M., Allore, H. G., Bendz, B., Bjorvatn, C., Borregaard, B., Brørs, G., Deaton, C., Fålun, N., Hadjistavropoulos, H., Hansen, T. B., Igland, S., Larsen, A. I., Palm, P., Pettersen, T. R., Rasmussen, T. B., Schjøtt, J., Søgaard, R., Valaker, I., Zwisler, A. D., Rotevatn, S., … CONCARD Investigators (2020). Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARD^PCI). BMJ Open. 2020 Feb 12;10(2):e031995.

 

• Karlsen T, Videm V, Halle M, Ellingsen Ø, Støylen A, Dalen H, Delagardelle C, Larsen AI, Hole T, Mezzani A, VAN Craenenbroeck EM, Beckers P, Pressler A, Christle JW, Winzer EB, Mangner N, Woitek FJ, Høllriegel R, Snoer M, Feiereisen P, Valborgland T, Linke A, Prescott E. Baseline and Exercise Predictors of V˙O2peak in Systolic Heart Failure Patients: Results from SMARTEX-HF. Med Sci Sports Exerc. 2020 Apr;52(4):810-819

 

• Valborgland T, Isaksen K, Yndestad A, Lindal S, Myreng K, Scott Munk P, Larsen AI. Increased functional capacity after 12 weeks of exercise training does not transform into improved skeletal muscle metabolism or ultrastructure in heart failure patients on modern optimal medical therapy. Eur J Prev Cardiol. 2020 Apr 28:2047487320919863. doi: 10.1177/2047487320919863. Epub ahead of print. PMID: 33611401.

 

• Butt, N., Bache-Mathiesen, L. K., Ushakova, A., Nordrehaug, E., Jensen, S. E., Munk, P. S., Danchin, N., Dubois-Rande, J. L., Hansen, H. S., Paganelli, F., Corvoisier, P. L., Firat, H., Erlinge, D., Atar, D., & Larsen, A. I. (2020). Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size. Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):302-312. 

 

• Stensjøen, A. L., Hommerstad, A., Halvorsen, S., Arheden, H., Engblom, H., Erlinge, D., Larsen, A. I., Sejersten Ripa, M., Clemmensen, P., Atar, D., & Hall, T. S. (2020). Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Ann Noninvasive Electrocardiol. 2020 Nov;25(6):e12784. 

 

• Tjelmeland, I., Alm-Kruse, K., Andersson, L. J., Bratland, S., Hafstad, A. K., Haug, B., Langørgen, J., Larsen, A. I., Lindner, T. W., Nilsen, J. E., Olasveengen, T. M., Soreide, E., Skogvoll, E., & Kramer-Johansen, J. (2020). Cardiac arrest as a reportable condition: a cohort study of the first 6 years of the Norwegian out-of-hospital cardiac arrest registry. BMJ Open. 2020 Jul 8;10(7):e038133. 

 

• Larsen AI. Aortic calcification; from innocent bystander to independent predictor; the delicate balance in biology; da Capo: Editorial accompanying 'Abdominal aortic calcification - from ancient friend to modern foe' [published online ahead of print, 2020 Jul 16]. Eur J Prev Cardiol.

 

• Bergland, A. K., Proitsi, P., Kirsebom, B. E., Soennesyn, H., Hye, A., Larsen, A. I., Xu, J., Legido-Quigley, C., Rajendran, L., Fladby, T., & Aarsland, D. (2020). Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease. J Alzheimers Dis. 2020;77(3):1117-1127.

 

• Larsen AI. The pulse; from adagio to prestissimo; the prognostic importance of heart rate increase and its associations with cardiovascular risk factors. Eur J Prev Cardiol. 2020 Mar;27(5):520-525.

 

• Aarsetøy, Reidun; Omland, Torbjørn; Røsjø, Helge; Strand, Heidi; Lindner, Thomas Werner; Aarsetøy, Hildegunn; Staines, Harry; Nilsen, Dennis W.T..
  N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: A prospective observational study. BMC Cardiovascular Disorders2020 ;Volum 20:382. s. 1-10.

 

• Bjørnestad, Espen Ø.; Olset, Hilde; Dhar, Indu; Løland, Kjetil Halvorsen; Pedersen, Eva Ringdal; Svingen, Gard Frodahl Tveitevåg; Svardal, Asbjørn M.; Berge, Rolf Kristian; Ueland, Per Magne; Tell, Grethe S.; Nilsen, Dennis W.T.; Nordrehaug, Jan Erik; Nygaard, Ellisif; Nygård, Ottar. Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. Journal of Internal Medicine2020 Oct;288(4):446-456. doi: 10.1111/joim.13067. Epub 2020 Apr 27.

 

• Dhar, Indu; Siddique, Sumia; Pedersen, Eva Ringdal; Svingen, Gard Frodahl Tveitevåg; Lysne, Vegard; Olsen, Thomas; Nilsen, Dennis W.T.; Nordrehaug, Jan Erik; Midttun, Øivind; Ueland, Per Magne; Tell, Grethe S.; Nygård, Ottar.
  Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin Coronary artery disease. Heart2020 Jul;106(14):1073-1079. doi: 10.1136/heartjnl-2019-316165. Epub 2020 May 12.

 

• Svenningsson, Mads Malm; Svingen, Gard Frodahl Tveitevåg; Lysne, Vegard; Ueland, Per Magne; Tell, Grethe S.; Pedersen, Eva Ringdal; Dhar, Indu; Nilsen, Dennis W.T.; Nygård, Ottar. Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. International Journal of Cardiology2020 Oct 15;317:75-80. doi: 10.1016/j.ijcard.2020.05.010. Epub 2020 May 8.

 

• Kalstad, Are; Myhre, Peder Langeland; Laake, Kristian; Tveit, Sjur Hansen; Schmidt, Erik Berg; Smith, Pål; Nilsen, Dennis W.T.; Tveit, Arnljot; Fagerland, Morten W; Solheim, Svein; Seljeflot, Ingebjørg; Arnesen, Harald. Effects of n-3 fatty acid supplementations in elderly patients after myocardial infarction: A randomized controlled trial. Circulation2020 Nov 15. doi: 10.1161/CIRCULATIONAHA.120.052209.

 

• Berge RK, Cacabelos D, Señarís R, Nordrehaug JE, Nygård O, Skorve J, Bjørndal B. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD⁺/NADH ratio. Lipids Health Dis. 2020 May 14;19(1):94. doi: 10.1186/s12944-020-01271-1. PMID: 32410680; PMCID: PMC7227213.

 

• Dhar I, Siddique S, R Pedersen E, F T Svingen G, Lysne V, Olsen T, Nilsen DW, Nordrehaug JE, Midttun Ø, M Ueland P, S Tell G, K Nygård O. Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. 2020 Jul;106(14):1073-1079. doi: 10.1136/heartjnl-2019-316165. Epub 2020 May 12. PMID: 32398245.

 

• Hellton KH, Cummings J, Vik-Mo AO, Nordrehaug JE, Aarsland D, Selbaek G, Giil LM. The Truth behind the Zeros: A New Approach to Principal Component Analysis of the Neuropsychiatric Inventory. Multivariate Behav Res. 2020 Apr 24:1-16. doi: 10.1080/00273171.2020.1736976. Epub ahead of print. PMID: 32329370.

 

• Lund A, Nordrehaug JE, Slettom G, Solvang SH, Pedersen EK, Midttun Ø, Ulvik A, Ueland PM, Nygård O, Giil LM. Plasma kynurenines and prognosis in patients with heart failure. PLoS One. 2020 Jan 10;15(1):e0227365. doi: 10.1371/journal.pone.0227365. Erratum in: PLoS One. 2020 Feb 27;15(2):e0230056. PMID: 31923223; PMCID: PMC6953806.

 

• Valaker I, Fridlund B, Wentzel-Larsen T, Nordrehaug JE, Rotevatn S, Råholm MB, Norekvål TM. Continuity of care and its associations with self-reported health, clinical characteristics and follow-up services after percutaneous coronary intervention. BMC Health Serv Res. 2020 Jan 31;20(1):71. doi: 10.1186/s12913-020-4908-1. PMID: 32005235; PMCID: PMC6993348.

 

• Królak A, Wiktorski T, Bjørkavoll-Bergseth MF, Ørn S. Artifact Correction in Short-Term HRV during Strenuous Physical Exercise. Sensors (Basel). 2020 Nov 8;20(21):6372. doi: 10.3390/s20216372. PMID: 33171676 Free PMC article.

 

• Kleiven Ø, Edvardsen T, Ørn S.Echocardiography in the pre-participation evaluation of asymptomatic athletes: the never-ending story. Eur J Prev Cardiol. 2020 Jun 24:2047487320932269. doi: 10.1177/2047487320932269. PMID: 32580569

 

• Wiktorski T, Bjørkavoll-Bergseth M, Ørn S. Methods for preprocessing time and distance series data from personal monitoring devices. MethodsX. 2020 Jun 12;7:100959. doi: 10.1016/j.mex.2020.100959. eCollection 2020. PMID: 32642451 Free PMC article.

 

• Kleiven Ø, Bjørkavoll-Bergseth MF, Omland T, Aakre KM, Frøysa V, Erevik CB, Greve OJ, Melberg TH, Auestad B, Skadberg Ø, Edvardsen T, Ørn S.Endurance exercise training volume is not associated with progression of coronary artery calcification. Scand J Med Sci Sports. 2020 Jun;30(6):1024-1032. doi: 10.1111/sms.13643. Epub 2020 Mar 18. PMID: 32100340

 

• Bjørkavoll-Bergseth M, Kleiven Ø, Auestad B, Eftestøl T, Oskal K, Nygård M, Skadberg Ø, Aakre KM, Melberg T, Gjesdal K, Ørn S. Duration of Elevated Heart Rate Is an Important Predictor of Exercise-Induced Troponin Elevation. J Am Heart Assoc. 2020 Feb 18;9(4):e014408. doi: 10.1161/JAHA.119.014408. Epub 2020 Feb 17. PMID: 32065043 Free PMC article.

 

• Grundtvig M, Eriksen-Volnes T, Ørn S, Slind EK, Gullestad L.  6 min walk test is a strong independent predictor of death in outpatients with heart failure. ESC Heart Fail. 2020 Oct;7(5):2904-2911. doi: 10.1002/ehf2.12900. Epub 2020 Jul 17. PMID: 32677748 Free PMC article.

 

• Kleiven Ø, Omland T, Skadberg Ø, Melberg TH, Bjørkavoll-Bergseth MF, Auestad B, Bergseth R, Greve OJ, Aakre KM, Ørn S Occult obstructive coronary artery disease is associated with prolonged cardiac troponin elevation following strenuous exercise. Eur J Prev Cardiol. 2020 Jul;27(11):1212-1221. doi: 10.1177/2047487319852808. Epub 2019 Jun 1. PMID: 31154829

 

• Skranes JB, Kleiven Ø, Aakre KM, Skadberg Ø, Melberg TH, Omland T, Ørn S. High-Sensitivity Cardiac Troponin I and T Response Following Strenuous Activity is Attenuated by Smokeless Tobacco: NEEDED (North Sea Race Endurance Exercise Study) 2014. J Am Heart Assoc. 2020 Oct 20;9(19):e017363. doi: 10.1161/JAHA.120.017363. Epub 2020 Sep 15. PMID: 32930023 Free PMC article.

 

• Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Skadberg Ø, Bonarjee VVS, Collinson P, Omland T, Vikenes K, Aakre KM. Cardiac Troponin Assays With Improved Analytical Quality: A Trade-Off Between Enhanced Diagnostic Performance and Reduced Long-Term Prognostic Value. J Am Heart Assoc. 2020 Dec;9(23):e017465. doi: 10.1161/JAHA.120.017465. Epub 2020 Nov 26. PMID: 33238783; PMCID: PMC7763786.

 

• Steiro OT, Tjora HL, Langørgen J, Bjørneklett R, Nygård OK, Skadberg Ø, Bonarjee VVS, Lindahl B, Omland T, Vikenes K, Aakre KM. Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study. Eur Heart J Acute Cardiovasc Care. 2020 Oct 2:zuaa016. doi: 10.1093/ehjacc/zuaa016. Online ahead of print. PMID: 33620429

 

• Nordfonn OK, Morken IM, Lunde Husebø AM. A qualitative study of living with the burden from heart failure treatment: Exploring the patient capacity for self-care. Nurs Open. 2020 Feb 8;7(3):804-813. doi: 10.1002/nop2.455. PMID: 32257268; PMCID: PMC7113501.

• Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF, Linssen GCM, Agema WRP, Anneveldt S, Lucas CMHB, Mannaerts HFJ, Wajon EMCJ, Dickstein K, Cramer MJ, Landman MAJ, Hoes AW, Rutten FH. Effectiveness of the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' and an e-health adjusted care pathway in patients with stable heart failure: results of the 'e-Vita HF' randomized controlled trial. Eur J Heart Fail. 2019 Feb;21(2):238-246.

 

• Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. Eur J Heart Fail. 2019 May;21(5):577-587

 

• Mordi IR, Santema BT, Kloosterman M, Choy AM, Rienstra M, van Gelder I, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Metra M, Ng LL, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Voors AA, Lang CC. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Colin Res Cardiol. 2019 Jul;108(7):797-805. doi: 10.1007/s00392-018-1409-x. Epub 2019 Jan 4.

 

• Steen T, Sciaraffia E, Normand C, Bogale N, Dickstein K, Linde C, Philbert BT. Contemporary practice of CRT implantation in scandinavia compared to Europe. Scand Cardiovasc J. 2019 Feb;53(1):9-13. doi: 10.1080/14017431.2019.1583364. Epub 2019 Mar 5.

 

• Papiashvili G, Machitidze G, Linde C, Normand C, Dickstein K. EUROPEAN CARDIAC RESYNCHRONIZATION THERAPY SURVEY II: COMPARISON OF RESULTS IN GEORGIA WITH OTHER COUNTRIES. Georgian Med News. 2019 Jan;(286):50-54.

 

• Cano Ó, Bellver A, Fontenla A, Villuendas R, Peñafiel P, Francisco-Pascual J, Ibáñez JL, Bertomeu-González V, García-Riesco L, García-Seara J, Martínez-Brotons Á, Calvo D, Campos B, Enero J, Peláez A, Martínez-Ferrer J, Mazuelos F, Moriñigo JL, Expósito C, Arenal Á, Pombo M, Segura F, Pastor A, Pérez F, Fernández-Lozano I, González-Ferrer JJ, Moreno S, Martín-Fernández J, Ormaetxe J, Pavón R, Tolosana JM, Mercé J, García-Almagro FJ, Álvarez M, Macías A, Peinado R, Linde C, Normand C, Dickstein K. Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II). Rev Esp Cardiol (Engl Ed). 2019 Dec;72(12):1020-1030. doi: 10.1016/j.rec.2019.02.003. Epub 2019 Mar 29. English, Spanish.

 

• Stienen S, Ferreira JP, Girerd N, Duarte K, Lamiral Z, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P; High-Risk Myocardial Infarction Database Initiative. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.Clin Res Cardiol. 2019 Nov;108(11):1215-1225. doi: 10.1007/s00392-019-01453-7. Epub 2019 Apr 5.

 

• Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Devalaraja M, Anker SD, Cleland JG, Dickstein K, Filippatos GS, van der Harst P, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, Zannad F, Zwinderman AH, Hillege HL, van Veldhuisen DJ, Kakkar R, Voors AA, van der Meer P. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. 2019 Aug;21(8):965-973. doi: 10.1002/ejhf.1482. Epub 2019 May 14.

 

• Emmens JE, Ter Maaten JM, Damman K, van Veldhuisen DJ, de Boer RA, Struck J, Bergmann A, Sama IE, Streng KW, Anker SD, Dickstein K, Lang CC, Metra M, Samani NJ, Ng LL, Voors AA. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure. Circ Heart Fail. 2019 May;12(5):e005544. doi: 10.1161/CIRCHEARTFAILURE.118.005544.

 

• Grote Beverborg N, van der Wal HH, Klip IT, Anker SD, Cleland J, Dickstein K, van Veldhuisen DJ, Voors AA, van der Meer P. Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies. JAMA Cardiol. 2019 Jul 1;4(7):696-701. doi: 10.1001/jamacardio.2019.1739.

 

• Gauthey A, Willems R, Vandekerckhove Y, Mullens W, Stefan L, Carryn X, Blommaert D, Mairesse G, Dickstein K, Normand C, Linde C, Le Polain de Waroux JB. Benchmarking Belgian CRT practice against the rest of Europe: insights from the ESC-CRT survey II. Acta Cardiol. 2019 Jun 13:1-5. doi: 10.1080/00015385.2019.1621455. [Epub ahead of print]

 

• Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, Hillege H, Samani NJ, Zannad F, Dickstein K, Lang CC, Cleland JG, Ter Maaten JM, Metra M, Anker SD, van der Harst P, Ng LL, van der Meer P, van Veldhuisen DJ, Meyer S, Lam CSP; ASIAN-HF investigators, Voors AA. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet. 2019 Oct 5;394(10205):1254-1263. doi: 10.1016/S0140-6736(19)31792-1. Epub 2019 Aug 22.

 

• Coiro S, Girerd N, Sharma A, Rossignol P, Tritto I, Pitt B, Pfeffer MA, McMurray JJV, Ambrosio G, Dickstein K, Moss A, Zannad F. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. Eur J Heart Fail. 2019 Oct;21(10):1248-1258. doi: 10.1002/ejhf.1541. Epub 2019 Sep 2.

 

• Tajstra M, Łasocha D, Gadula-Gacek E, Ostręga M, Michalak L, Wojciechowski D, Zieliński M, Kempa M, Orski Z, Polewczyk A, Ozga J, Normand C, Dickstein K, Linde C, Kaźmierczak J, Szumowski Ł, Gąsior M, Sterliński M. Cardiac resynchronization in Poland - comparable procedural routines? Insights from CRT Survey II. Postepy Kardiol Interwencyjnej. 2019;15(4):477-484. doi: 10.5114/aic.2019.90223. Epub 2019 Dec 8.

 

• Docherty KF, Shen L, Castagno D, Petrie MC, Abraham WT, Böhm M, Desai AS, Dickstein K, Køber LV, Packer M, Rouleau JL, Solomon SD, Swedberg K, Vazir A, Zile MR, Jhund PS, McMurray JJV. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail. 2019 Dec 17. doi: 10.1002/ejhf.1682. [Epub ahead of print]

 

• Lawin D, Israel CW, Linde C, Normand C, Dickstein K, Lober C, Gitt AK, Hindricks G, Stellbrink C; members of the European CRT Survey II of the EHRA/HFA/ESC. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. Clin Res Cardiol. 2019 Dec 6. doi: 10.1007/s00392-019-01574-z. [Epub ahead of print]

 

• Galand V, Linde C, Lellouche N, Mansourati J, Deharo JC, Sagnol P, Da Costa A, Horvilleur J, Defaye P, Boveda S, Steinbach M, Bru P, Rumeau P, Beard T, Younsi S, Dickstein K, Normand C, Leclercq C. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France. Arch Cardiovasc Dis. 2019 Nov;112(11):713-722. doi: 10.1016/j.acvd.2019.09.005. Epub 2019 Nov 6.

 

• van der Wal HH, Grote Beverborg N, Dickstein K, Anker SD, Lang CC, Ng LL, van Veldhuisen DJ, Voors AA, van der Meer P. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J. 2019 Nov 21;40(44):3616-3625. doi: 10.1093/eurheartj/ehz680.

 

• Auricchio A, Gasparini M, Linde C, Dobreanu D, Cano Ó, Sterlinski M, Bogale N, Stellbrink C, Refaat MM, Blomström-Lundqvist C, Lober C, Dickstein K, Normand C. Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 Patients. JACC Clin Electrophysiol. 2019 Sep;5(9):1048-1058. doi: 10.1016/j.jacep.2019.06.003. Epub 2019 Jul 31.

 

 

• asocha, Damian; Sterliski, Maciej; Tajstra, Mateusz; Josiak, Krystian; Zajc, Dariusz; Tluczek, Slawomir; Sokal, Adam; Januszkiewicz, ukasz J.; Galar, Bogdan; Sznajder, Rafa; Kamierczak, Jarosaw; Szumowski, ukasz; Normand, Camilla Jaqueline Hansine; Linde, Cecilia; Dickstein, Kenneth. Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II registry. Kardiologia polska 2019 ;Volum 77.(1) s.40-46 SUS UiB

 

• Cao, Thong H.; Jones, Donald J.L.; Voors, Adriaan A.; Quinn, Paulene A.; Sandhu, Jatinderpal K.; Chan, Daniel C.S.; Parry, Helen M.; Mohan, Mohapradeep; Mordi, Ify R.; Sama, Iziah E.; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos; Hillege, Hans L.; Metra, Marco; Ponikowski, Piotr; Samani, Nilesh J.; van Veldhuisen, Dirk J.; Zannad, Faïez; Lang, Chim C.; Ng, Leong L.. Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. European Journal of Heart Failure 2019 s.1-11 SUS UiB

 

 

• Dewan, Pooja; Rørth, Rasmus; Jhund, Pardeep S.; Ferreira, João Pedro; Zannad, Faïez; Shen, Li; Køber, Lars; Abraham, William T. Desai, Akshay S.; Dickstein, Kenneth; Packer, Milton; Rouleau, Jean-Lucien; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.; McMurray, John J. V.. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. Heart failure 2019 ;Volum 7.(4) s.336-346 SUS UiB

 

• Dewan, Pooja; Rørth, Rasmus; Jhund, Pardeep S.; Shen, Li; Raparelli, Valeria; Petrie, Mark C.; Abraham, William T.; Desai, Akshay S.; Dickstein, Kenneth; Køber, Lars; Mogensen, Ulrik M.; Packer, Milton; Rouleau, Jean L.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.; McMurray, John J.V. Differential impact of heart failure with reduced ejection fraction on men and women. Journal of the American College of Cardiology 2019 ;Volume N73.(1) s.29-40SUS UiB

 

• Ferreira, João Pedro; Metra, Marco; Anker, Stefan D.; Dickstein, Kenneth; Lang, Chim C.; Ng, Leong; Samani, Nilesh J.; Cleland, John G.; van Veldhuisen, Dirk J.; Voors, Adriaan A.; Zannad, Faïez. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTATCHF study. European Journal of Heart Failure 2019 ;Volum 21.(2) s.218-226 SUS UiB

 

• Hall, Trygve Sørdahl; von Lueder, Thomas Gero; Zannad, Faïez; Rossignol, Patrick; Duarte, Kévin; Chouihed, Tahar; Solomon, Scott D.; Dickstein, Kenneth; Atar, Dan; Agewall, Stefan; Girerd, Nicolas. Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. American Heart Journal 2019 ;Volum 215. s.83-9 OUS SUS UiB UiO

 

• Santema, Bernadet T.; Chan, Michelle M.Y.; Tromp, Jasper; Dokter, Martin; van der Wal, Haye H.; Emmens, Johanna Elisabeth; Takens, Janny; Samani, Nilesh J.; Ng, Leong L.; Lang, Chim C.; van der Meer, Peter; ter Maaten, Jozine M.; Damman, Kevin; Dickstein, Kenneth; Cleland, John G.; Zannad, Faiez; Anker, Stefan D.; Metra, Marco; van der Harst, Pim; de Boer, Rudolf A.; van Veldhuisen, Dirk J. Rienstra, Michiel; Lam, Carolyn S.P.; Voors, Adriaan A.. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology 2019 s.1-8 SUS UiB

 

• Schulz, Jörn; Kvaløy, Jan Terje; Engan, Kjersti; Eftestøl, Trygve Christian; Jatosh, Samwel; Hussein, Kidanto; Ersdal, Hege Langli. Steen, Torkel; Sciaraffia, Elena; Normand, Camilla Jaqueline Hansine; Bogale, Nigussie; Dickstein, Kenneth; Linde, Cecilia; Philbert Berit T.. Contemporary practice of CRT implantation in scandinavia compared to Europe. Scandinavian Cardiovascular Journal 2019 ;Volum 53.(1) s.9-13 OUS SUS UiB SUS

 

• Mordi, Ify R.; Santema, Bernadet T.; Kloosterman, Mariëlle; Choy, Anna-Maria; Rienstra, Michiel; van Gelder, Isabelle; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos; van der Harst, Pim; Hillege, Hans L.; Metra, Marco; Ng, Leong L.; Ouwerkerk, Wouter; Ponikowski, Piotr; Samani, Nilesh J.; van Veldhuisen, Dirk J.; Zwinderman, Aelko H.; Zannad, Faiez; Voors, Adriaan A.; Lang, Chim C.. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation. Clinical Research in Cardiology 2019 s.1-9 SUS UiB

 

 

• Nauta, Jan F.; Hummel, Yoran M.; Tromp, Jasper; Ouwerkerk, Wouter; van der Meer, Peter; Jin, Xuanyi; Lam, Carolyn S.P.; Bax, Jeroen J.; Metra, Marco; Samani, Nilesh J.; Ponikowski, Piotr; Dickstein, Kenneth; Anker, Stefan D; Lang, Chim C.; Ng, Leong L.; Zannad, Faïez; Filippatos, Gerasimos S.; van Veldhuisen, Dirk J.; van Melle, Joost P.; Voors, Adriaan A.. Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment. European Journal of Heart Failure 2019 s.1-9 SUS UiB

 

• ter Maaten, Jozine M.; Kremer, Daan; Demissei, Biniyam G.; Struck, Joachim; Bergmann, Andreas; Anker, Stefan D.; Ng, Leong L.; Dickstein, Kenneth; Metra, Marco; Samani, Nilesh J.; Romaine, Simon P.R.; Cleland, John; Girerd, Nicolas; Lang, Chim C.; van Veldhuisen, Dirk Jan; Voors, Adriaan A. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure. European Journal of Heart Failure 2019 21(6):732-743 SUS UiB

 

• Normand, Camilla Jaqueline Hansine; Kaye, David M.; Povsic, Thomas J.; Dickstein, Kenneth. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. The Lancet 2019 ;Volum 393.(10175) s.1045-1055 SUS UiB

 

• Normand, Camilla Jaqueline Hansine; Linde, Cecilia; Bogale, Nigussie; Blomström-Lundqvist, Carina; Auricchio, Angelo; Stellbrink, Christoph; Witte, Klaus K.; Mullens, Wilfried; Sticherling, Christian; Marinskis, Germanas; Sciaraffia, Elena; Papiashvili, Giorgi; Iovev, Svetoslav; Dickstein, Kenneth. Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II. Europace 2019 ;Volum 21.(6) s.918-927 SUS UiB
1. Kontny

 

 

• Terum, Toril Marie; Testad, Ingelin; Rongve, Arvid; Aarsland, Dag; Svendsboe, Ellen J; Andersen, John Roger. Ueland, Thor; Åkerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika; Becker, Richard C.; Bertilsson, Maria; Himmelmann, Anders; James, Stefan K.; Siegbahn, Agneta; Storey, Robert F.; Kontny, Frederic; Aukrust, Pål; Wallentin, Lars. Admission levels of DKK1 (Dickkopf-1) are associated with future cardiovascular death in patients with acute coronary syndromes. Arteriosclerosis, Thrombosis and Vascular Biology 2019 ;Volum 39.(2) s.294-302 OUS SUS UiO UiT

 

• Ueland T, Åkerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Budaj A, Cornel JH, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. 2019 Nov 29;293:35-41.

 

• Furtado RHM, Nicolau JC, Magnani G, Im K, Bhatt DL, Storey RF, Steg PG, Spinar J, Budaj A, Kontny F, Corbalan R, Kiss RG, Abola MT, Johanson P, Jensen EC, Braunwald E, Sabatine MS, Bonaca MP. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. Eur Heart J. 2019 Dec 7.

 

• Andersen T, Ueland T, Ghukasyan Lakic T, Åkerblom A, Bertilsson M, Aukrust P, Michelsen AE, James SK, Becker RC, Storey RF, Wallentin L, Siegbahn A, Kontny F. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2402-2410.

 

• Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. 2019 Sep 28;394(10204):1169-1180.

 

• Dellborg M, Bonaca MP, Storey RF, Steg PG, Im KA, Cohen M, Bhatt DL, Oude Ophuis T, Budaj A, Hamm C, Spinar J, Kiss RG, Lopez-Sendon J, Kamensky G, Van de Werf F, Ardissino D, Kontny F, Montalescot G, Johanson P, Bengtsson O, Himmelmann A, Braunwald E, Sabatine MS.Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54. Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):200-206.

 

• Kontny F, Andersen T, Ueland T, Åkerblom A, Lakic TG, Michelsen AE, Aukrust P, Bertilsson M, Becker RC, Himmelmann A, James SK, Siegbahn A, Storey RF, Wallentin L; PLATO Investigators Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2019 Apr 24:2048872619846334.

 

• Franchi F, James SK, Ghukasyan Lakic T, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Storey RF, Himmelmann A, Wallentin L, Angiolillo DJ; PLATO Investigators.Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y₁₂Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial. J Am Heart Assoc. 2019 Mar 19;8(6):e011139. doi: 10.1161/JAHA.118.011139. PMID:

 

• Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstråle W, Held C, Steg PG; THEMIS Steering Committee. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clin Cardiol. 2019 May;42(5):498-505. doi: 10.1002/clc.23164. Epub 2019 Apr 9. PMID:

 

• Ueland T, Åkerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):294-302.

 

• Bergland, Anne Katrine; Sønnesyn, Hogne; Dalen, Ingvild; Rodriguez-Mateos, Ana; Berge, Rolf Kristian; Melvær, Giil Lasse; Rajendran, Lawrence; Siow, Richard; Tassotti, Michele; Larsen, Alf Inge; Aarsland, Dag. Effects of anthocyanin supplementation on serum lipids, glucose, markers of inflammation and cognition in adults with increased risk of dementia A pilot study. Frontiers in Genetics 2019 ;Volum 10:536. s.1-11 HVprivate SUS UiB

 

• Larsen, Alf Inge; Valborgland, Torstein; Ogne, Christer; Lindal, Sigurd; Halvorsen, Bente; Munk, Peter Scott; Kvaløy, Jan Terje; Aukrust, Pål; Yndestad, Arne. Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role in myopathy. European Journal of Preventive Cardiology 2019 s.1-5 OUS SUS

 

• Isaksen, Kjetil; Halvorsen, Bente; Munk, Peter Scott; Aukrust, Pål; Larsen, Alf Inge. Effects of interval training on inflammatory biomarkers in patients with ischemic heart failure. Scandinavian Cardiovascular Journal 2019 ;Volum 53.(4) s.213-219 OUS SSHF SUS UiB UiO

 

• Karlsen, Trine; Videm, Vibeke; Halle, Martin; Ellingsen, Øyvind; Støylen, Asbjørn; Dalen, Håvard; Delagardelle, Charles; Larsen, Alf Inge; Hole, Torstein; Mezzani, Alessandro; Craenenbrock, EM; Beckers, Patrick; Pressler, Axel; Christle, JW; Winzer, Ephraim; Mangner, Norman; Woitek, Felix; Höllriegel, Robert; Snoer, Martin; Feiereisen, Patrick; Valborgland, Torstein; Linke, Axel; Prescott, Eva Irene Bossano. Baseline and Exercise Predictors of VO2peak in Systolic Heart Failure Patients: Results from SMARTEX-HF.. Medicine & Science in Sports & Exercise 2019 NORD HMR HNT NTNU STO SUS UiB

 

• Khanmohammadi, Mahdieh; Engan, Kjersti; Sæland, Charlotte; Eftestøl, Trygve Christian; Larsen, Alf Inge. Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris. Frontiers in Cardiovascular Medicine 2019 ;Volum 6. SUS UiB UIS

 

• Munkhaugen, John; Ruddox, Vidar; Halvorsen, Sigrun; Dammen, Toril; Fagerland, Morten; Hernæs, Kjersti Helene; Vethe, Nils Tore; Prescott, Eva; Jensen, Svend Eggert; Rødevand, Olaf; Jortveit, Jarle; Bendz, Bjørn; Schirmer, Henrik; Kõber, Lars; Botker, Hans Erik; Larsen, Alf Inge; Vikenes, Kjell; Steigen, Terje; Wiseth, Rune; Pedersen, Terje Rolf; Edvardsen, Thor; Otterstad, Jan Erik; Atar, Dan. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduce left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end-point study. American Heart Journal 2019 ;Volum 208. s.37-46 AHUS HAUKELAND LHL OUS SIV SSHF STO SUS UiO UiT UNN VV

 

• Larsen AI. The pulse; from adagio to prestissimo; the prognostic importance of heart rate increase and its associations with cardiovascular risk factors. Eur J Prev Cardiol. 2019 Sep 3:2047487319872690.

 

• Vikse, Jens; Sæland, Charlotte; Ogne, Christer; Greve, Ole Jacob; Johnsen, Svein Joar Auglæn. Aneurismer i koronararterier. Tidsskrift for Den norske legeforening 2019 ;Volum 139.(2) s.1-5

 

• Olie, Renske H; van der Meijden, P; Spronk, Henk MH; van Oerle, Rene; Barvik, Ståle; Bonarjee, Vernon V S; ten Cate, Jacob M.; Nilsen, Dennis W.T.. Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease. TH Open 2019 ;Volum 3. s.e259-e262 SUS UiB

 

• Ten Cate H, Kontny F, Nilsen DW. Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease. Front Cardiovasc Med. 2019 May 22;6:66

 

 

• Melvær, Giil Lasse; Solvang, Stein-Erik Hafstad; Giil, Malin Melvaer; Hellton, Kristoffer Herland; Skogseth, Ragnhild Eide; Vik-Mo, Audun Osland; Hortobágyi, Tibor; Aarsland, Dag; Nordrehaug, Jan Erik. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia. Journal of Alzheimer's Disease 2019 ;Volum 68.(1) s.239-253

 

• Valaker I, Fridlund B, Wentzel-Larsen T, Hadjistavropoulos H, Nordrehaug JE, Rotevatn S, Råholm MB, Norekvål TM; CONCARD Investigators. Adaptation and psychometric properties of the Norwegian version of the heart continuity of care questionnaire (HCCQ).

 

• Kleiven, Øyunn; Omland, Torbjørn; Skadberg, Øyvind; Melberg, Tor Harald; Bjørkavoll-Bergseth, Magnus; Auestad, Bjørn Henrik;Bergseth, Rolf; Greve, Ole Jacob; Aakre, Kristin Moberg; Ørn, Stein. Occult obstructive coronary artery disease is associated with prolonged cardiac troponin elevation following strenuous exercise. European Journal of Preventive Cardiology 2019 s.1-10 AHUS HAUKELAND SUS UiB UiO UIS

 

• Kleiven, Øyunn; Omland, Torbjørn; Skadberg, Øyvind; Melberg, Tor Harald; Bjørkavoll-Bergseth, Magnus; Auestad, Bjørn Henrik, Bergseth, Rolf; Greve, Ole Jacob; Aakre, Kristin Moberg; Ørn, Stein. Race duration and blood pressure are major predictors of exercise-induced cardiac troponin elevation. International Journal of Cardiology 2019 ;Volum 283. s.1-8 AHUS HAUKELAND SUS UiB UiO UIS

 

• Le, Kjell; Eftestøl, Trygve Christian; Engan, Kjersti; Kleiven, Øyunn; Ørn, Stein. Baseline Wander Removal and Isoelectric Correction in Electrocardiograms Using Clustering. Proceedings of the IEEE International Conference on Acoustics, Speech and Signal Processing 2019 ;Volum 2019-May. s.1274-1278 SUS UIS

 

• Le, Kjell; Eftestøl, Trygve Christian; Engan, Kjersti; Kleiven, Øyunn; Ørn, Stein. Validation of Baseline Wander Removal and Isoelectric Correction in Electrocardiograms Using Clustering. European Signal Processing Conference 2019 SUS UIS

 

 

• Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP; PARAGON-HF Investigators and Committees.Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019 Oct 24;381(17):1609-1620.

 

• Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

 

• Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.

 

• Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Renstrøm R, Skadberg Ø, Bonarjee VVS, Lindahl B, Collinson P, Omland T, Vikenes K, Aakre KM. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design. Scand Cardiovasc J. 2019 Oct;53(5):280-285.

 

 

• Nordfonn OK, Morken IM, Bru LE, Husebø AML.Patients' experience with heart failure treatment and self-care-A qualitative study exploring the burden of treatment. J Clin Nurs. 2019 May;28(9-10):1782-1793.

 

2020

 

• Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.PMID: 31504439

 

• Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, Dickstein K, Lang CC, Filippatos G, Anker SD, Ponikowski P, Metra M, van Veldhuisen DJ, Voors AA. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020 May 14;41(19):1810-1817. doi: 10.1093/eurheartj/ehaa373.PMID: 32388565 

 

• Docherty KF, Shen L, Castagno D, Petrie MC, Abraham WT, Böhm M, Desai AS, Dickstein K, Køber LV, Packer M, Rouleau JL, Solomon SD, Swedberg K, Vazir A, Zile MR, Jhund PS, McMurray JJV. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail. 2020 Mar;22(3):528-538. doi: 10.1002/ejhf.1682. Epub 2019 Dec 17.PMID: 31849164

 

• Tromp J, Voors AA, Sharma A, Ferreira JP, Ouwerkerk W, Hillege HL, Gomez KA, Dickstein K, Anker SD, Metra M, Lang CC, Ng LL, van der Harst P, van Veldhuisen DJ, van der Meer P, Lam CSP, Zannad F, Sama IEDistinct Pathological Pathways in Patients With Heart Failure and Diabetes. .JACC Heart Fail. 2020 Mar;8(3):234-242. doi: 10.1016/j.jchf.2019.11.005. Epub 2020 Feb 5.PMID: 32035890

 

• Kloosterman M, Santema BT, Roselli C, Nelson CP, Koekemoer A, Romaine SPR, Van Gelder IC, Lam CSP, Artola VA, Lang CC, Ng LL, Metra M, Anker S, Filippatos G, Dickstein K, Ponikowski P, van der Harst P, van der Meer P, van Veldhuisen DJ, Benjamin EJ, Voors AA, Samani NJ, Rienstra M.Genetic risk and atrial fibrillation in patients with heart failure. Eur J Heart Fail. 2020 Mar;22(3):519-527. doi: 10.1002/ejhf.1735. Epub 2020 Jan 9.PMID: 31919934 

 

• Simpson J, Jhund PS, Lund LH, Padmanabhan S, Claggett BL, Shen L, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, Mueller-Velten G, Solomon SD, Swedberg K, Zile MR, McMurray JJV.Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure. JAMA Cardiol. 2020 Apr 1;5(4):432-441. doi: 10.1001/jamacardio.2019.5850.PMID: 31995119

• Bogale N. Beware the possibly life-threatening leak. Int J Cardiol. 2018 Dec 1;272:229-230.

• Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. Eur J Heart Fail. 2018 Dec 10. doi: 10.1002/ejhf.1347. [Epub ahead of print]

 

• Brusich, Sandro; Zeljkovi, Ivan; Pavlovic, Nikola; Ani, Ante; Juriši, Zrinka; Židan, David; Klasan, Marina; ubrani, Zlatko; Dickstein,Kenneth; Linde, Cecilia; Normand, Camilla Jaqueline Hansine; Manola, Sime.Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II MulticenterRegistry. Cardiology Research and Practice 2018 ;Volum 2018.Cardiol Res Pract. 2018 Oct 25;2018:3479846.

 

 

• Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF, Linssen GCM, Agema WRP, Anneveldt S, Lucas CMHB, Mannaerts HFJ, Wajon EMCJ, Dickstein K, Cramer MJ, Landman MAJ, Hoes AW, Rutten FH. Effectiveness of the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' and an e-health adjusted care pathway in patients with stable heart failure: results of the 'e-Vita HF' randomized controlled trial.Eur J Heart Fail. 2019 Feb;21(2):238-246.

 

• Streng, Koen W.; Nauta, Jan F.; Hillege, Hans L.; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos; Lang,Chim C.; Metra, Marco; Ng, Leong L.; Ponikowski, Piotr; Samani, Nilesh J.; van Veldhuisen, Dirk J.; Zwinderman, Ailko H.; Zannad,Faiez; Damman, Kevin; van der Meer, Peter; Voors, Adriaan A..Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology 2018SUS UiB

 

 

• Streng, Koen W.; Voors, Adriaan A.; Hillege, Hans L.; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos; Metra, Marco; Ng, Leong L.; Ponikowski, Piotr; Samani, Nilesh J.; van Veldhuisen, Dirk J.; Zwinderman, Aeilko H.; Zannad, Faiez; Damman, Kevin; van der Meer, Peter; Lang, Chim C.. Waist-to-hip ratio and mortality in heart failure. European Journal of Heart Failure 2018 ;Volum 20.(9) s.1269-1277 SUS UiB

 

• Cao, Thong Huy; Jones, Donald J.L.; Quinn, Paulene A.; Chan, Daniel Chu Siong; Hafid, Narayan; Parry, Helen M.; Mohan, Mohapradeep; Sandhu, Jatinderpal K.; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos; Hillege, Hans L.; Metra, Marco; Ponikowski, Piotr; Samani, Nilesh J.; van Veldhuisen, Dirk J.; Zannad, Faiez; Zwinderman, Aeilko H.; Voors, Adriaan A.;Lang, Chim C.; Ng, Leong L..Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure. Clinical Proteomics 2018 ;Volum 15:35. s.1-9

 

 

• Łasocha D, Sterliński M, Tajstra M, Josiak K, Zając D, Tłuczek S, Sokal A, Januszkiewicz ŁJ, Galar B, Sznajder R, Kaźmierczak J, Szumowski Ł, Normand C, Linde C, Dickstein K. Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II Registry. Kardiol Pol. 2019;77(1):40-46.

 

• Suzuki T, Yazaki Y, Voors AA, Jones DJL, Chan DCS, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, Ng LL.Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure (from BIOSTAT-CHF).Eur J Heart Fail. 2018 Oct 29.

 

• Ferreira JP, Metra M, Mordi I, Gregson J, Ter Maaten JM, Tromp J, Anker SD, Dickstein K, Hillege HL, Ng LL, van Veldhuisen DJ, Lang CC, Voors AA, Zannad F.Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.Eur J Heart Fail. 2019 Jan;21(1):112-120.

 

• Rossello X, Ferreira JP, McMurray JJ, Aguilar D, Pfeffer MA, Pitt B, Dickstein K, Girerd N, Rossignol P, Zannad F; High-Risk Myocardial Infarction Database Initiative.Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.Eur Heart J Acute Cardiovasc Care. 2018 Sep 27:2048872618803701.

 

• Dobre D, Kjekshus J, Rossignol P, Girerd N, Benetos A, Dickstein K, Zannad F. Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure. Int J Cardiol. 2018 Nov 15;271:181-185.

 

• Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Lang CC, Ng LL, Zannad F, Zwinderman AH, Hillege HL, van der Meer P, Voors AA. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. J Am Coll Cardiol. 2018 Sep 4;72(10):1081-1090.

 

• Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N; High-Risk Myocardial Infarction Database Initiative investigators. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. Int J Cardiol. 2018 Dec 1;272:260-266.

 

• Zeljkovic I, Burri H, Breitenstein A, Ammann P, Mueller A, Auricchio A, Delacrétaz E, Dickstein K, Linde C, Normand C, Sticherling C. Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland.Swiss Med Wkly. 2018 Aug 22;148:w14643.

 

• Santema BT, Kloosterman M, Van Gelder IC, Mordi I, Lang CC, Lam CSP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Van der Harst P, Hillege HL, Ter Maaten JM, Metra M, Ng LL, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, Van der Meer P, Rienstra M, Voors AA. Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. Eur Heart J. 2018 Nov 14;39(43):3867-3875. << First< PrevPage of 20Next >Last

 

• Varma N, Sogaard P, Bax JJ, Abraham WT, Borer JS, Dickstein K, Singh JP, Gras D, Holzmeister J, Brugada J, Ruschitzka F. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial. J Am Heart Assoc. 2018 May 27;7(11). pii: e009592. 23.

 

• Linde CM, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, Sticherling C, Bulava A, Pérez ÓC, Maass AH, Witte KK, Rekvava R, Abdelali S, Dickstein K.Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail. 2018 Oct;20(10):1457-1468.

 

• Ferreira JP, Duarte K, Pitt B, Dickstein K, McMurray JJV, Zannad F, Rossignol P.Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials.J Hypertens. 2018 Aug;36(8):1736-1742.

 

• Frikha Z, Ferreira JP, Bozec E, McMurray JJV, Pitt B, Dickstein K, Rossignol P, Zannad F, Girerd N; High-Risk Myocardial Infarction Database Initiative Investigators.Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative). Am J Cardiol. 2018 May 1;121(9):1015-1020.

 

• Normand C, Linde C, Singh J, Dickstein K.Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines. JACC Heart Fail. 2018 Apr;6(4):308-316.

 

• Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, Olsen NT, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F, Sogaard P.Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes. J Am Coll Cardiol. 2018 Mar 27;71(12):1325-1333

 

• ESC Board .The future of continuing medical education: the roles of medical professional societies and the health care industry: Position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, Endorsed by the Board of the European Society of Cardiology. Eur Heart J. 2018 Feb 28.

 

• Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R.Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. Eur J Heart Fail. 2018 May;20(5):888-895.

 

• Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, Stellbrink C, Anker SD, Filippatos G, Gasparini M, Hindricks G, Blomström Lundqvist C, Ponikowski P, Ruschitzka F, Botto GL, Bulava A, Duray G, Israel C, Leclercq C, Margitfalvi P, Cano Ó, Plummer C, Sarigul NU, Sterlinski M, Linde C.CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?Eur J Heart Fail. 2018 Jun;20(6):1039-1051.
• Ferreira JP, Girerd N, Gregson J, Latar I, Sharma A, Pfeffer MA, McMurray JJV, Abdul-Rahim AH, Pitt B, Dickstein K, Rossignol P, Zannad F; High-Risk Myocardial Infarction Database Initiative.Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.J Am Coll Cardiol. 2018 Feb 20;71(7):727-735. 32.

 

• Normand C, Dickstein K.Guideline recommendations for cardiac resynchronization therapy evolve but does clinical practice match the pace? Eur J Heart Fail. 2018 Apr;20(4):778-779. doi: 10.1002/ejhf.1148. Epub 2018 Feb 12. No abstract available.

 

• Ouwerkerk W, Zwinderman AH, Ng LL, Demissei B, Hillege HL, Zannad F, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Ter Maaten JM, Lang CC, van der Harst P, Filippatos G, Dickstein K, Cleland JG, Anker SD, Voors AA.Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. J Am Coll Cardiol. 2018 Jan 30;71(4):386-398.

 

• Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P.Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. Eur J Heart Fail. 2018 May;20(5):923-930.

 

• Ferreira JP, Duarte K, Pfeffer MA, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P; High-Risk Myocardial Infarction Database Initiative.Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative. Eur J Heart Fail. 2018 Feb;20(2):323-331.

 

• Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH.Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol. 2018 Feb 15;253:84-90. 37.

 

• Emmens JE, Jones DJL, Cao TH, Chan DCS, Romaine SPR, Quinn PA, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, de Boer RA, Voors AA, Ng LL.Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. Eur J Heart Fail. 2018 Feb;20(2):260-267.

 

• Kristensen SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, Ali MA, Shao Q, Chiang Y, Jhund PS, Abraham WT, Dickstein K, McMurray JJV, Køber L. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. Eur J Heart Fail. 2018 Jan;20(1):136-147

 

• Howlett J, Comin-Colet J, Dickstein K, Fuat A, Pölzl G, Delaney S.Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey. ESC Heart Fail. 2018 Feb;5(1):172-183. doi: 10.1002/ehf2.12205. Epub 2017 Sep 18. Review.

 

• Ferreira JP, Rossignol P, Demissei B, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F.Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. 2018 Apr;104(7):606-613.

 

• Linde CM, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, Sticherling C, Bulava A, Pérez ÓC, Maass AH, Witte KK, Rekvava R, Abdelali S, Dickstein K. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail. 2018 Oct;20(10):1457-1468

 

• Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, Stellbrink C, Anker SD, Filippatos G, Gasparini M, Hindricks G, Blomström Lundqvist C, Ponikowski P, Ruschitzka F, Botto GL, Bulava A, Duray G, Israel C, Leclercq C, Margitfalvi P, Cano Ó, Plummer C, Sarigul NU, Sterlinski M, Linde C. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. 2018 Jun;20(6):1039-1051.
• Bonarjee VVS. Arterial Stiffness: A Prognostic Marker in Coronary Heart Disease. Available Methods and Clinical Application. Front Cardiovasc Med. 2018;5:64

 

• Larsen AI. The muscle hypothesis in heart failure revised: 'The multisite training approach'. Eur J Prev Cardiol. 2018 Aug;25(12):1252-1256.

 

• Valborgland T, Isaksen K, Munk PS, Grabowski ZP, Larsen AI. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy : A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study. J Nucl Cardiol. 2018;25:1164-1171.

 

• Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Shah DJ, Cheong B, Sejersten M, Birnbaum Y.Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging. J Electrocardiol. 2018;5:218-223.

 

• Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y. Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging. J Electrocardiol. 2018;51:563-568.

 

• Fakhri Y, Sejersten M, Schoos MM, Hansen HS, Dubois-Rande JL, Hall TS, Larsen AI, Jensen SE, Engblom H, Arheden H, Kastrup J, Atar D, Clemmensen P. Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction. J Electrocardiol. 2018;51:195-202.

 

 

• Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y. The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2018;23:e12580

 

• Husebø AML, Morken IM, Eriksen KS, Nordfonn OK. The patient experience with treatment and self-management (PETS) questionnaire: translation and cultural adaption of the Norwegian version. BMC Med Res Methodol. 2018;18:14

 

• Aarsetøy R, Aarsetøy H, Hagve TA, Strand H, Staines H, Nilsen DWT. Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients with Documented Ventricular Fibrillation. Frontiers in Cardiovascular Medicine 2018; 5.(44): 1-11.

 

• Degerud E, Nygård O, De Vogel S, Hoff R, Svingen GFT, Pedersen ER, Nilsen DWT, Nordrehaug JE, Midttun Ø, Ueland PM, Dierkes J. Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism 2018; 103(3): 1161-1170

 

 

• Mjelva Ø, Svingen GFT, Pedersen ER, Seifert R, Kvaløy JT, Midttun Ø, Ueland PM, Nordrehaug JE, Nygård O, Nilsen DWT. Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease. Thrombosis and Haemostasis 2018; 118(4): 778-790.

 

• Svingen GFT, Zuo H, Ueland PM, Seifert R, Løland KH, Pedersen ER, Schuster P, Karlsson T, Tell GS, Schartum-Hansen H, Olset H, Svenningsson MM, Strand E, Nilsen DWT, Nordrehaug JE, Dhar I, Nygård O. Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology 2018; 267: 100-06.
• Zuo H, Nygård O, Ueland PM, Vollset SE, Svingen, GFT, Pedersen ER, Midttun Ø, Meyer K, Nordrehaug JE, Nilsen DWT, Tell GS. Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. Journal of Internal Medicine 2018; 283(6): 578-587.

 

• Zuo H, Svingen GFT, Tell GS, Ueland PM, Vollset SE, Pedersen ER, Ulvik A, Meyer K, Nordrehaug JE, Nilsen DWT, Bønaa K, Nygård O. Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. Journal of the American Heart Association 2018; 7(8): 1-11.

 

 

• Eide LS, Ranhoff AH, Lauck S, Fridlund B, Haaverstad R, Hufthammer KO, Kuiper KKJ, Nordrehaug JE, Norekvål TM; Indwelling urinary catheters, aortic valve treatment and delirium: a prospective cohort study.CARDELIR Investigators. BMJ Open. 2018;8(11):e021708. doi: 10.1136/bmjopen-2018-021708.
• Bjørndal B, Bruheim I, Lysne V, Ramsvik MS, Ueland PM, Nordrehaug JE, Nygård OK, Berge RK. Plasma choline, homocysteine and vitamin status in healthy adults supplemented with krill oil: a pilot study. Scand J Clin Lab Invest. 2018 Nov - Dec;78(7-8):527-532. doi: 10.1080/00365513.2018.1512716. Epub 2018 Sep 27

 

• Skaar E, Eide LSP, Norekvål TM, Ranhoff AH, Nordrehaug JE, Forman DE, Schoenenberger AW, Ove Hufthammer K, Kuiper KK, Bleie Ø, Langørgen J, Haaverstad R, Schaufel MA. A novel Geriatric Assessment frailty score predicts two-year mortality after Transcatheter Aortic Valve implantation. Eur Heart J Qual Care Clin Outcomes. 2018 Sep 25. doi: 10.1093/ehjqcco/qcy044. [Epub ahead of print]

 

• Pettersen TR, Fridlund B, Bendz B, Nordrehaug JE, Rotevatn S, Schjøtt J, Norekvål TM; Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective. CONCARD Investigators.Int J Nurs Stud. 2018 Dec;88:16-24.

 

 

• Giil LM, Aarsland D, Hellton K, Lund A, Heidecke H, Schulze-Forster K, Riemekasten G, Vik-Mo AO, Kristoffersen EK, Vedeler CA, Nordrehaug JE Alzheimer's Disease: A Longitudinal Study. J Alzheimers Dis. 2018;64(3):761-774.

 

• Vogelsang P, Giil LM, Lund A, Vedeler CA, Parkar AP, Nordrehaug JE, Kristoffersen EK Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients.. Brain Res. 2018 Jan 1;1678:304-309.

 

• Packer EJS, Slettom G, Solholm A, Mongstad A, Haaverstad R, Tuseth V, Grong K, Nordrehaug JE Left Versus Biventricular Assist Devices in Cardiac Arrest..ASAIO J. 2018;64:489-496.

 

• Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure. Lund A, Giil LM, Slettom G, Nygaard O, Heidecke H, Nordrehaug JE. Int J Cardiol. 2018 Jan 1;250:253-259.
• Pönitz V, Evensen KJ. 87-year-old woman with improved pulmonary function following accidental long-term inhalation therapy with dabigatran. BMJ Case Rep. 2018;2018

 

• Svendsen IS, Tønnesen E, Tjelta LI, Ørn S. Training, Performance, and Physiological Predictors of a Successful Elite Senior Career in Junior Competitive Road Cyclists. Int J Sports Physiol Perform. 2018 Nov 20:1-6. doi: 10.1123/ijspp.2017-0824. [Epub ahead of print] PubMed PMID: 29745739

 

• Vikse J, Ørn S, Jeroen de Romijn B, Greve OJ, Norheim KB. [Cardiac sarcoidosis]. Tidsskr Nor Laegeforen. 2018 Feb 19;138(4).

 

 

• Skadberg Ø, Kleiven Ø, Ørn S, Bjørkavoll-Bergseth MF, Melberg TH, Omland T, Aakre KM. The cardiac troponin response following physical exercise in relation to biomarker criteria for acute myocardial infarction; the North Sea Race Endurance Exercise Study (NEEDED) 2013. Clin Chim Acta. 2018 Apr;479:155-159. doi: 10.1016/j.cca.2018.01.033. Epub 2018 Feb 2. PubMed PMID: 29366834.

 

• Aakre KM, Kleiven Ø, Skadberg Ø, Bjørkavoll-Bergseth MF, Melberg T, Strand H, Hagve TA, Ørn S. The copeptin response after physical activity is not associated with cardiac biomarkers or asymptomatic coronary artery disease: The North Sea Race Endurance Exercise Study (NEEDED) 2013. Clin Biochem. 2018 Feb;52:8-12. doi: 10.1016/j.clinbiochem.2017.10.007. Epub 2017 Oct 26. PubMed PMID: 29079359.

 

• Kleiven Ø, Bjørkavoll-Bergseth M, Melberg T, Skadberg Ø, Bergseth R, Selvåg J, Auestad B, Aukrust P, Aarsland T, Ørn S. High physical fitness is associated with reduction in basal- and exercise-induced inflammation. Scand J Med Sci Sports. 2018 Jan;28(1):172-179. doi: 10.1111/sms.12878. Epub 2017 Apr 12. PubMed PMID: 28314078.

 

• Le K, Eftestøl T, Engan K, Kleiven Ø, Ørn S. Invariant electrical mean axis in electrocardiogram. Computing in cardiology. ISSN 2325-8861.

 

• Kleiven Ø, Ørn, S. Endurance exercise and myocardial injury. Eur J Prev Cardiol 2018 doi: 10.1177/2047487318815302. {Epub ahead of print] 2018 Nov 30.

 

• Ørn S, kapittel om hjerte-kar legemidler i “Legemidler og bruken av dem”, 3.utgave Gyldendal Akademiske 2018, ISBN 9788205508637

 

• Dlugosz D, Eftestøl TC, Krolak A, Wiktorski T, Ørn S The North Sea Bicycle Race ECG Project: Time-Domain Analysis, J Automation, Mobile Robotics & Int Systems. 2018;12:23-32, DOI 14313/JAMRIS_1-2018/3

• Sæland C, Melberg T, Bogale N. Spontan koronar arteriedisseksjon.Tidsskr Nor Laegeforen. 2017 May 2;137(9):631-633, Aakre KM, Kleiven Ø, Skadberg Ø, Bjørkavoll-Bergseth MF, Melberg T, Strand H, Hagve TA, Ørn S. The copeptin response after physical activity is not associated with cardiac biomarkers or asymptomatic coronary artery disease: The North SeaRace Endurance Exercise Study (NEEDED) 2013. Clin Biochem. 2017 Oct 26. pii:S0009-9120(17)30829-9. doi: 10.1016/j.clinbiochem.2017.10.007. [Epub ahead ofprint] PubMed PMID: 29079359.

 

• Kleiven Ø, Bjørkavoll-Bergseth M, Melberg T, Skadberg Ø, Bergseth R, Selvåg J, Auestad B, Aukrust P, Aarsland T, Ørn S. High physical fitness is associated with reduction in basal- and exercise-induced inflammation. Scand J Med Sci Sports.2017 Mar 17. doi: 10.1111/sms.12878. [Epub ahead of print] PubMed PMID: 28314078.

 

• Skadberg Ø, Kleiven Ø, Bjørkavoll-Bergseth M, Melberg T, Bergseth R, Selvåg J, Auestad B, Greve OJ, Dickstein K, Aarsland T, Ørn S. Highly increased Troponin I levels following high-intensity endurance cycling may detect subclinical coronary artery disease in presumably healthy leisure sport cyclists: The North Sea Race Endurance Exercise Study (NEEDED) 2013. Eur J Prev Cardiol. 2017 May;24(8):885-894. doi: 10.1177/2047487317693130. Epub 2017 Feb 10. PubMed PMID: 28186443.

 

• Apeland T, Danielsen T, Staal EM, Åsberg A, Thorsen IS, Dalsrud TO, Ørn S. Risk factors for exertional rhabdomyolysis with renal stress. BMJ Open Sport Exerc Med. 2017 Jul 6;3(1):e000241. doi: 10.1136/bmjsem-2017-000241. eCollection 2017. PubMed PMID: 29147573; PubMed Central PMCID: PMC5680435.

 

• Ørn S, van Hall G. Does a normal peripheral lactate value always indicate an aerobic tissue metabolism? Eur J Heart Fail. 2017 Aug;19(8):1034-1035. doi: 10.1002/ejhf.863. Epub 2017 May 25. PubMed PMID: 28547836.

 

• Kleiven Ø, Ørn S. P-wave axis as a predictor of mortality. Eur J Prev Cardiol. 2017 Dec;24(18):1991-1993. doi: 10.1177/2047487317739044. Epub 2017 Oct 30.PubMed PMID: 29083242.

 

• Długosz D, Królak A, Eftestøl TC, Ørn S, Wiktorski T. The North Sea Bicycle Race ECG Project: Time-Domain Analysis. Proceedings of the Federated Conference on Computer Science and Information Systems 2017, ISSN 2300-5963 ACSIS, Vol. 11. 1353–1356 DOI: 10.15439/2017F303,

 

• Nilsen, DWT, Aarsetøy H, Pønitz V, Andersen TB; Staines, Harry; Harris, William S; Grundt, Heidi. The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease.. International Journal of Cardiology 2017 ;Volum 249. s. 12-17.

 

 

• Næsgaard P, Grundt H, Nordøy A, Staines H, Nilsen DWT. Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine 2017 ;Jul 24;4:41. doi: 10.3389/fcvm.2017.00041. eCollection 2017 (6 sider)

 

• Vogelsang P, Giil LM, Lund A, Vedeler CA, Parkar AP, Nordrehaug JE, Kristoffersen EK.Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients. Brain Res. 2018 Jan 1;1678:304-309. doi: 10.1016/j.brainres.2017.10.035. Epub 2017 Nov 2.

 

• Packer EJS, Slettom G, Solholm A, Mongstad A, Haaverstad R, Tuseth V, Grong K, Nordrehaug JE. ASAIO J. Left Versus Biventricular Assist Devices in Cardiac Arrest. 2017 Oct 20. doi: 10.1097/MAT.0000000000000694. [Epub ahead of print]

 

• Lund A, Giil LM, Slettom G, Nygaard O, Heidecke H, Nordrehaug JE. Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure. Int J Cardiol. 2018 Jan 1;250:253-259. doi: 10.1016/j.ijcard.2017.10.013. Epub 2017 Oct 5.

 

• Oterhals K, Haaverstad R, Nordrehaug JE, Eide GE, Norekvål TM. Self-reported health status, treatment decision and survival in asymptomatic and symptomatic patients with aortic stenosis in a Western Norway population undergoing conservative treatment: a cross-sectional study with 18 months follow-up. BMJ Open. 2017 Aug 21;7(8):e016489. doi: 10.1136/bmjopen-2017-016489.

 

• Giil LM, Vedeler CA, Kristoffersen EK, Nordrehaug JE, Heidecke H, Dechend R, Schulze-Forster K, Muller DN, von Goetze VS, Cabral-Marques O, Riemekasten G, Vogelsang P, Nygaard S, Lund A, Aarsland D. Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function. J Alzheimers Dis. 2017;59(3):929-939. doi: 10.3233/JAD-170245.

 

• Valaker I, Norekvål TM, Råholm MB, Nordrehaug JE, Rotevatn S, Fridlund B; CONCARD Investigators. Continuity of care after percutaneous coronary intervention: The patient's perspective across secondary and primary care settings. Eur J Cardiovasc Nurs. 2017 Jun;16(5):444-452. doi: 10.1177/1474515117690298. Epub 2017 Jan 1.

 

• Skaar E, Ranhoff AH, Nordrehaug JE, Forman DE, Schaufel MA. Conditions for autonomous choice: a qualitative study of older adults' experience of decision-making in TAVR. J Geriatr Cardiol. 2017 Jan;14(1):42-48. doi: 10.11909/j.issn.1671-5411.2017.01.007.

 

• Nordrehaug JE, Wiseth R, Bønaa KH. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. N Engl J Med. 2016 Dec 29;375(26):2604-2605. doi: 10.1056/NEJMc1613866. No abstract available.

 

• Veum VL, Laupsa-Borge J, Eng Ø, Rostrup E, Larsen TH, Nordrehaug JE, Nygård OK, Sagen JV, Gudbrandsen OA, Dankel SN, Mellgren G. Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: a randomized controlled trial. Am J Clin Nutr. 2017 Jan;105(1):85-99. doi: 10.3945/ajcn.115.123463. Epub 2016 Nov 30.

 

• Butt N, Bache-Mathiesen LK, Nordrehaug JE, Tuseth V, Munk PS, Bonarjee V, Hall TS, Jensen SE, Halvorsen S, Firat H, Atar D, Larsen AI. Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins. Cardiology. 2017;138(2):122-132. doi: 10.1159/000475460. Epub 2017 Jun 27.

 

• Fakhri Y, Sejersten M, Schoos MM, Hansen HS, Dubois-Rande JL, Hall TS, Larsen AI, Jensen SE, Engblom H, Arheden H, Kastrup J, Atar D, Clemmensen P. Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction. J Electrocardiol. 2017 Nov 13

 

 

• Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Shah DJ, Cheong B, Sejersten M, Birnbaum Y. Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging. J Electrocardiol. 2017 Oct 6.

 

• Larsen AI. Strength and aerobic exercise training in coronary artery disease; it's not 'either-or'. Eur J Prev Cardiol. 2017 Jan 1:2047487317726201. doi:

 

• Kirkegaard H, Søreide E, de Haas I, Pettilä V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sørensen CA, Ilkjær S, Jeppesen AN, Grejs AM, Duez CHV, Hjort J, Larsen AI, Toome V, Tiainen M, Hästbacka J, Laitio T, Skrifvars MB. Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2017;318:341-350

 

• Ellingsen Ø, Halle M, Conraads V, Støylen A, Dalen H, Delagardelle C, Larsen AI, Hole T, Mezzani A, Van Craenenbroeck EM, Videm V, Beckers P, Christle JW, Winzer E, Mangner N, Woitek F, Höllriegel R, Pressler A, Monk-Hansen T, Snoer M, Feiereisen P, Valborgland T, Kjekshus J, Hambrecht R, Gielen S, Karlsen T, Prescott E, Linke A; SMARTEX Heart Failure Study (Study of Myocardial Recovery After Exercise Training in Heart Failure) Group. High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction. Circulation. 2017;135:839-849

 

• Valborgland T, Munk S, Kvaløy JT, Grabowski, Larsen AI. Impact of an exercise-training programme on cardiac neuronal function in heart failure patients on optimal medical therapy. J Nucl Cardiol. 2017 Jan 17. doi: 10.1007/s12350-016-0724-8. [Epub ahead of print]

 

• Bergland AK, Sønnesyn H, Larsen AI, Dalen I, Aarsland D.Effect of vascular risk factors on the progression of mild Alzheimer’s disease and Lewy body dementia. J Alzheimers Dis. 2017;56(2):575-584

 

• Røysland IØ, Friberg F, Støre Brinchmann B, Nordeide Svello S, Valborgland T, Larsen AI. Confronting one's vulnerability - patients with chest pain participating in a high-intensity exercise programme.J Clin Nurs. 2017 Jul;26(13-14):2006-2015

 

• Mahdieh Khanmohammadi, Charlotte Sæland, Kjersti Engan, Alf Inge Larsen, Trygve Eftestøl Segmentation of Coronary Arteries from X-ray Angiogram Using Image EUSIPCO2017

 

• Wollert KC, Meyer GP, Müller-Ehmsen J, Tschöpe C, Bonarjee V, Larsen AI, May AE, Empen K, Chorianopoulos E, Tebbe U, Waltenberger J, Mahrholdt H, Ritter B, Pirr J, Fischer D, Korf-Klingebiel M, Arseniev L, Heuft HG, Brinchmann JE, Messinger D, Hertenstein B, Ganser A, Katus HA, Felix SB, Gawaz MP, Dickstein K, Schultheiss HP, Ladage D, Greulich S, Bauersachs Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Eur Heart J. 2017;38:2936-2943

 

 

• Grejs AM, Nielsen BRR, Juhl-Olsen P, Gjedsted J, Sloth E, Heiberg J, Frederiksen CA, Jeppesen AN, Duez CHV, Hamre PD, Søreide E, Kirkegaard H. Effect of prolonged targeted temperature management on left ventricular myocardial function after out-of-hospital cardiac arrest - A randomised, controlled trial. 2017;115:23-31.

 

• Emmens JE, Jones DJL, Cao TH, Chan DCS, Romaine SPR, Quinn PA, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, de Boer RA, Voors AA, Ng LL. Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. Eur J Heart Fail. 2017 Dec 18. doi: 10.1002/ejhf.1101. [Epub ahead of print]PMID:29251807

 

• Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010. PMID: 29306478

 

• Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV; Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction. PARADIGM-HF and ATMOSPHERE Investigators and Committees. J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027. PMID: 29145948

 

• Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV; Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. PARADIGM-HF and ATMOSPHERE Investigators and Committees. Circ Heart Fail. 2017 Nov;10(11). pii: e004361. doi: 10.1161/CIRCHEARTFAILURE.117.004361. PMID:29141857

 

• Bayes-Genis A, Núñez J, Zannad F, Ferreira JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Metra M, Lupón J, Voors AA. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis. J Am Coll Cardiol. 2017 Oct 24;70(17):2128-2136. doi: 10.1016/j.jacc.2017.08.057. PMID: 29050560

 

• Wolsk E, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber L, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Circulation. 2017 Oct 17;136(16):1560-1562. doi: 10.1161/CIRCULATIONAHA.117.029503. No abstract available. PMID: 29038210

 

• Dickstein K.Heartfailurematters.org. Eur Heart J. 2017 Oct 7;38(38):2861-2862. doi: 10.1093/eurheartj/ehx571. No abstract available. PMID: 29019621

 

• Kristensen SL, Jhund PS, Mogensen UM, Rørth R, Abraham WT, Desai A, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV; Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. PARADIGM-HF and ATMOSPHERE Committees and Investigators. Circ Heart Fail. 2017 Oct;10(10). pii: e004409. doi: 10.1161/CIRCHEARTFAILURE.117.004409. PMID: 29018174

 

• Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N; Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative. High Risk Myocardial Infarction Database Initiative investigators. Int J Cardiol. 2017 Dec 15;249:274-281. doi: 10.1016/j.ijcard.2017.09.182. Epub 2017 Sep 24. PMID: 28964557
• Kristensen SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, Ali MA, Shao Q, Chiang Y, Jhund PS, Abraham WT, Dickstein K, McMurray JJV, Køber L. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. Eur J Heart Fail. 2017 Sep 25. doi: 10.1002/ejhf.896. [Epub ahead of print] PMID: 28948656

 

• Howlett J, Comin-Colet J, Dickstein K, Fuat A, Pölzl G, Delaney S. Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey. ESC Heart Fail. 2017 Sep 18. doi: 10.1002/ehf2.12205. [Epub ahead of print] PMID:28921886

 

• Wagenaar KP, Rutten FH, Klompstra L, Bhana Y, Sieverink F, Ruschitzka F, Seferovic PM, Lainscak M, Piepoli MF, Broekhuizen BDL, Strömberg A, Jaarsma T, Hoes AW, Dickstein K. 'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions. Eur J Heart Fail. 2017 Nov;19(11):1447-1454. doi: 10.1002/ejhf.917. Epub 2017 Sep 4. PMID:28871622

 

• Ferreira JP, Rossignol P, Demissei B, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F. Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750. [Epub ahead of print] PMID:28798192

 

• Steen T, Dickstein K.Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width? Eur J Heart Fail. 2017 Sep;19(9):1152-1153. doi: 10.1002/ejhf.904. Epub 2017 Jun 19. No abstract available. PMID: 28626904

 

• Ferreira JP, Rossignol P, Machu JL, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ter Maaten JM, Metra M, Ng L, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017 Oct;19(10):1284-1293. doi: 10.1002/ejhf.900. Epub 2017 Jun 5. PMID:28580625

 

• Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017 May 29;6(6). pii: e004743. doi: 10.1161/JAHA.116.004743. PMID:28554908

 

• Dickstein K. Early clinical benefit after cardiac resynchronization therapy: fortunately, QRS width and ejection fraction are still the best predictors. Eur J Heart Fail. 2017 Aug;19(8):1064-1066. doi: 10.1002/ejhf.865. Epub 2017 May 25. No abstract available. PMID: 28547811

 

• Tajik AA, Dobre D, Aguilar D, Kjekshus J, Zannad F, Dickstein K A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database.; High-Risk MI Database Scientific Committee. Eur J Heart Fail. 2017 May;19(5):635-642. doi: 10.1002/ejhf.797. PMID: 28485550

 

• Coiro S, Girerd N, Rossignol P, Bauersachs J, Pitt B, Fay R, Ambrosio G, Solomon SD, Dickstein K, Zannad F. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative. Clin Res Cardiol. 2017 Sep;106(9):722-733. doi: 10.1007/s00392-017-1116-z. Epub 2017 Apr 28. PMID: 28455597

 

• Bax JJ, Delgado V, Sogaard P, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Brugada J, Robertson M, Ford I, Krum H, Holzmeister J, Ruschitzka F, Gorcsan J. Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial. Eur Heart J. 2017 Mar 7;38(10):720-726. doi: 10.1093/eurheartj/ehw506. PMID:28426885

 

• Packer M, O'Connor C, McMurray JJV, Wittes J, Abraham WT, Anker SD, Dickstein K, Filippatos G, Holcomb R, Krum H, Maggioni AP, Mebazaa A, Peacock WF, Petrie MC, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Kowarski LS, Schactman M, Holzmeister J; Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. TRUE-AHF Investigators. N Engl J Med. 2017 May 18;376(20):1956-1964. doi: 10.1056/NEJMoa1601895. Epub 2017 Apr 12. PMID:28402745

 

• Ouwerkerk W, Voors AA, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Ter Maaten JM, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Metra M, Zwinderman AH. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study. Eur Heart J. 2017 Jun 21;38(24):1883-1890. doi: 0.1093/eurheartj/ehx026. PMID:28329163

 

• Voors AA, Ouwerkerk W, Zannad F, van Veldhuisen DJ, Samani NJ, Ponikowski P, Ng LL, Metra M, Ter Maaten JM, Lang CC, Hillege HL, van der Harst P, Filippatos G, Dickstein K, Cleland JG, Anker SD, Zwinderman AH. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017 May;19(5):627-634. doi: 10.1002/ejhf.785. Epub 2017 Mar 1. PMID:28247565

 

• Ferreira JP, Girerd N, Duarte K, Coiro S, McMurray JJ, Dargie HJ, Pitt B, Dickstein K, Testani JM, Zannad F, Rossignol P; Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative. High-Risk Myocardial Infarction Database Initiative Investigators. Circ Heart Fail. 2017 Feb;10(2). pii: e003500. doi: 10.1161/CIRCHEARTFAILURE.116.003500. PMID:28159825

 

• Nägele MP, Steffel J, Robertson M, Singh JP, Flammer AJ, Bax JJ, Borer JS, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, Abraham WT, Brugada J, Ruschitzka F. Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT. Eur J Heart Fail. 2017 Jan;19(1):80-87. doi: 10.1002/ejhf.655. Epub 2016 Nov 11. PMID:27862715

 

• Packer M, Holcomb R, Abraham WT, Anker S, Dickstein K, Filippatos G, Krum H, Maggioni AP, McMurray JJV, Mebazaa A, O'Connor C, Peacock F, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Holzmeister J Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
1. ; TRUE-AHF Investigators and Committees.
2. Eur J Heart Fail. 2017 May;19(5):673-681. doi: 10.1002/ejhf.698. Epub 2016 Nov 13. PMID:27862700

 

• Coiro S, Girerd N, Rossignol P, Ferreira JP, Maggioni A, Pitt B, Tritto I, Ambrosio G, Dickstein K, Zannad F. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative. Eur J Heart Fail. 2017 Feb;19(2):271-279. doi: 10.1002/ejhf.647. Epub 2016 Oct 24. PMID:27774703

 

• Lindholm D, James SK, Bertilsson M, Becker RC, Cannon CP, Giannitsis E, Harrington RA, Himmelmann A, Kontny F, Siegbahn A, Steg PG, Storey RF, Velders MA, Weaver WD, Wallentin L; PLATO Investigators Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2017 Feb;63(2):573-584.